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Abstract
Bartonella spp. are facultative intracellular bacteria that typically cause a long-
lasting intraerythrocytic bacteremia in their mammalian reservoir hosts,
thereby favoring transmission by blood-sucking arthropods. In most cases, nat-
ural reservoir host infections are subclinical and the relapsing intraerythrocytic
bacteremia may last weeks, months, or even years. In this review, we will fol-
low the infection cycle of Bartonella spp. in a reservoir host, which typically
starts with an intradermal inoculation of bacteria that are superficially
scratched into the skin from arthropod feces and terminates with the pathogen
exit by the blood-sucking arthropod. The current knowledge of bacterial coun-
termeasures against mammalian immune response will be presented for each
critical step of the pathogenesis. The prevailing models of the still-enigmatic
primary niche and the anatomical location where bacteria reside, persist, and
are periodically seeded into the bloodstream to cause the typical relapsing
Bartonella spp. bacteremia will also be critically discussed. The review will end
up with a discussion of the ability of Bartonella spp., namely Bartonella hense-
lae, Bartonella quintana, and Bartonella bacilliformis, to induce tumor-like vas-
cular deformations in humans having compromised immune response such as
in patients with AIDS.
Introduction
Bartonella spp. are Gram-negative facultative intracellular
bacteria that taxonomically belong to the a2-subgroup of
the proteobacteria. Bartonella spp. have peculiar and
demanding nutritional requirements such as the apparent
inability to utilize glucose as the carbon source (Cheno-
weth et al., 2004). Typically, the bacteria are grown
in vitro on sheep blood or chocolate agar plates under
5% CO2 atmosphere, and this may easily take several days
or even weeks with primary isolates for visible colonies to
appear. This creates challenges in clinical settings despite
complementary serological and molecular approaches
(Agan & Dolan, 2002). There have been attempts to
establish liquid growth media and growth conditions
(Schwartzman et al., 1993; Wong et al., 1995a; Cheno-
weth et al., 2004; Maggi et al., 2005; Riess et al., 2008),
which improve isolation and also have great value for
basic research, for example, in the analysis of Bartonella
spp. pathogenic mechanisms.
Figure 1 outlines the phylogeny of Bartonella spp.,
which is based on nucleotide sequence information of
478 core genome genes of the ten currently available
Bartonella spp. genomes and four house-keeping genes
(rpoB, gltA, ribC, and groEL) of nonsequenced Bartonella
spp. (Engel et al., 2011). Based on the work by Engel and
co-workers, Bartonella spp. can be separated into four
phylogenetic clades. First clade is represented by a single
species, Bartonella bacilliformis, which is highly patho-
genic in its human reservoir host. Clades 2, 3, and 4 con-
tain species that cause more benign infections in their
reservoir hosts as well as species such as Bartonella hense-
lae, which represents a significant zoonotic threat to
humans. At least one mammalian reservoir host is known
for each of the described member of the genus Bartonella,
that is, the bacterium has been cultivated from the blood
of the corresponding mammal. Bartonella spp.–arthropod
interactions remain poorly defined. However, Bartonella
spp. have been detected from a number of blood-sucking
arthropods either directly by molecular diagnostics or
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after conventional culture recovery (Fig. 1) (Chomel
et al., 2009b). Moreover, infection studies under labora-
tory conditions indicate that blood-sucking arthropods
act as vectors of Bartonella spp. As an example, cat fleas
(Ctenocephalides felis) that had been feeding on B. hense-
lae-infected cats efficiently transmitted the bacterium into
pathogen-free cats (Chomel et al., 1996). Fleas (Ctenoph-
thalmus nobilis nobilis) that were harvested from wild
voles have also been reported to transmit Bartonella grah-
amii and Bartonella taylorii into pathogen-free voles
under laboratory conditions (Bown et al., 2004). Most
likely flea feces and superficial scratching of the skin
mediate the actual transmission. It has been shown that
intradermal inoculation of cats with B. henselae-contain-
ing flea feces causes bacteremia (Foil et al., 1998).
The common theme in Bartonella spp. infection of the
reservoir mammalian host is a chronic intraerythrocytic
bacteremia (Abbott et al., 1997; Schu¨lein et al., 2001),
which appears to be a specific adaptation to the mode of
transmission by blood-sucking arthropods. In incidental
hosts, Bartonella spp. do not appear to establish the intra-
erythrocytic bacteremia. However, endothelial cells (ECs)
appear to be targeted by Bartonella spp. both in the inci-
dental host and in the reservoir host. Infections of the
Fig. 1. Phylogeny and epidemiology of Bartonella spp. Bartonella spp. typically cause persistent and relapsing intraerythrocytic bacteremia in
their mammalian reservoir hosts, thereby favoring transmission by blood-sucking arthropods. Incidental mammalian hosts may get infected via
direct contact with the infected arthropod, with their feces, or with the infected animal. Phylogeny is modified from Engel et al. (2011), and it
contains most of the currently known Bartonella species. Epidemiological data are based on (Engbaek & Lawson, 2004; Reeves et al., 2007)
Bartonella vinsonii ssp. vinsoni, (Breitschwerdt et al., 1995; Chang et al., 2000; Roux et al., 2000; Breitschwerdt et al., 2009; Schaefer et al.,
2011) Bartonella vinsonii ssp. berkhoffii, (Welch et al., 1999; Fenollar et al., 2005; Bai et al., 2010, 2011b) Bartonella vinsonii ssp. arupensis,
(Heller et al., 1999; Raoult et al., 2006; Angelakis et al., 2008; Kernif et al., 2010) Bartonella alsatica, (Birtles et al., 1995; Bown et al., 2004;
Engbaek & Lawson, 2004; Marie´ et al., 2006) Bartonella taylorii, (Birtles et al., 1995; Kerkhoff et al., 1999; Koesling et al., 2001; Bown et al.,
2004; Engbaek & Lawson, 2004; Berglund et al., 2010) Bartonella grahamii, (Daly et al., 1993; O’Halloran et al., 1998; Ellis et al., 1999;
Ying et al., 2002; Inoue et al., 2009; Tsai et al., 2010) Bartonella elizabethae, (Heller et al., 1998; Engbaek & Lawson, 2004; Li et al., 2007;
Reeves et al., 2007; Tsai et al., 2010; Billeter et al., 2011) Bartonella tribocorum, (Droz et al., 1999; Rolain et al., 2003a; Avidor et al., 2004;
Marie´ et al., 2006; Ohad et al., 2010; Mascarelli et al., 2011; Pe´rez et al., 2011) Bartonella koehlerae, (English et al., 1988; Welch et al., 1992;
Wong et al., 1995b, Chomel et al., 1996; Abbott et al., 1997; Rolain et al., 2003a; Ohad et al., 2010; Mascarelli et al., 2011; Pe´rez et al., 2011;
Regnery et al., 1992; Tsai et al., 2011) Bartonella henselae, (Fournier et al., 2001; Foucault et al., 2002; Safdar, 2002; George et al., 2006;
Marie´ et al., 2006; Breitschwerdt et al., 2007; Vitale et al., 2009; Holmes et al., 2011; Huang et al., 2011; Yamada et al., 2011) Bartonella
quintana, (Birtles et al., 1995; Marie´ et al., 2006; Telfer et al., 2007) Bartonella doshiae, (Bermond et al., 2000; Engbaek & Lawson, 2004; Reis
et al., 2011) Bartonella birtlesii, (Chomel et al., 2009b; Gabriel et al., 2009; Henn et al., 2009; Schaefer et al., 2011) Bartonella rochalimae,
(Lin et al., 2008; Engel et al., 2011) Bartonella sp. 1-1C, (Inoue et al., 2009) Bartonella sp. AR15-3, (Heller et al., 1997; Kordick et al., 1997;
Sander et al., 2000b; Rolain et al., 2003a; Tsai et al., 2011) Bartonella clarridgeiae, (Bermond et al., 2002; Chung et al., 2004; Pe´rez et al.,
2011) Bartonella bovis, (Maillard et al., 2004) Bartonella chomelii, (Bermond et al., 2002; Bai et al., 2011a) Bartonella capreoli, (Dehio et al.,
2001; Rolain et al., 2003b; Dehio et al., 2004) Bartonella schoenbuchensis, and (Schultz, 2010) Bartonella bacilliformis.
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reservoir hosts range from an apparently asymptomatic to
subclinical (most animal-specific species), low morbidity
to limited mortality (such as human-specific Bartonella
quintana infections), and even to life-threatening, such as
the severe hemolytic anemia associated with the human-
specific infection by B. bacilliformis (Maguin˜a et al.,
2009). In most cases, infections of the reservoir hosts do
not lead to severe disease symptoms (Chomel et al., 1996;
Regnery et al., 1996; Abbott et al., 1997; Guptill et al.,
1997; O’Reilly et al., 1999; Pappalardo et al., 2000; Bou-
louis et al., 2001; Koesling et al., 2001; Pappalardo et al.,
2001; Schu¨lein et al., 2001; Zhang et al., 2004; Marignac
et al., 2010), suggesting a highly specific adaptation to the
corresponding host and circumvention of its immune
responses.
A significant progress in our understanding of the
molecular and cellular basis of Bartonella spp. pathogene-
sis (Tables 1 and 2) has been achieved in recent years
because of the establishment of bacterial genetics as well
as animal and cell culture infection models. This review
will focus on the current knowledge of mammalian host–
Bartonella spp. interaction and excludes the arthropod
host–Bartonella spp. interaction, which has recently been
reviewed (Chomel et al., 2009b). The main emphasis is
laid on the description of Bartonella spp. tool-box to effi-
ciently circumvent and subvert host antimicrobial func-
tions and to establish the typical chronic and relapsing
infection. In the end, the most significant Bartonella spp.
human infections and their vasoproliferative tumor-like
manifestations bacillary angiomatosis (BA), bacillary peli-
osis (BP), and verruga peruana of the Carrion’s disease
will be discussed in light of the proposed molecular
mechanisms of pathogenesis. Bartonella spp.-triggered
tumorigenesis has attracted considerable interest from
both clinicians and basic scientists in the fields of infec-
tion and cancer biology, and it represents a paradigm for
pathogen-triggered tumorigenesis.
Progression of Bartonella spp. infection
in the reservoir mammalian host
One of the strengths of the Bartonella spp. research field
is the ability to conduct infection studies in natural reser-
voir hosts such as a mouse, cat, rat, or a dog, with the
most detailed information available for the rat model of
Bartonella tribocorum infection (Schu¨lein et al., 2001).
The first reservoir host models, however, were established
for B. henselae in domestic cats (Chomel et al., 1996;
Regnery et al., 1996; Abbott et al., 1997; Guptill et al.,
1997; O’Reilly et al., 1999). Bartonella henselae infection
Table 1. Synopsis of the proposed pathogenicity factors of Bartonella spp.
Factor Description with key reference(s)
LPS Weak TLR4 agonist (Za¨hringer et al., 2004)
Flagella Weak TLR5 agonist, important in bacterial motility and possibly in bacterial adhesion to the erythrocytes
(Andersen-Nissen et al., 2005)
BadA, BrpA, VompA, VompB,
VompC, VompD
TAAs induce auto-aggregation, antiphagocytic properties, bind multiple ECM components, mediate cell
adhesion, essential for intraerythrocytic bacteremia by B. tribocorum (BadA), B. quintana (Vomps), and
B. birtlesii (BrpA), required in colonization of the primary niche and/or in seeding of the bacteria from the
primary niche into the bloodstream (Riess et al., 2004; Zhang et al., 2004; Gilmore et al., 2005)
Pap31 Fibronectin-binding adhesin, also known as hemin-binding protein A (HbpA) (Dabo et al., 2006a, b)
Hemolysin Hemolysin of B. bacilliformis, proposed to mediate erythrocyte lysis in the end of Oroya fever (Hendrix,
2000)
VirB/VirD4-T4SS Type IV secretion system that mediates by its BepB effector proteins (BepA-G) the invasome-mediate
uptake of B. henselae into ECs and inhibition of EC apoptosis, essential for intraerythrocytic bacteremia
by B. tribocorum and B. birtlesii, required in the colonization of the primary niche and/or in seeding of the
bacteria from the primary niche into the bloodstream (Schulein & Dehio, 2002)
Trw–T4SS Type IV secretion system that mediates the erythrocyte adhesion of Bartonella spp., essential for
intraerythrocytic bacteremia by B. tribocorum and B. birtlesii (Seubert et al., 2003)
Deformin Induces deeply invaginated pits and trenches in the erythrocytes, presumably involved in the invasion of
the erythrocytes, small molecule (~1.4 kDa) that binds albumin (Derrick & Ihler, 2001)
IalAB Involved in the invasion of the erythrocytes, IalB is similar to Ail invasion of Y. enterocolitica, IalA is a
nucleoside polyphosphate hydrolase of the MutT motif family, both proteins are required for the
erythrocyte invasion, essential for intraerythrocytic bacteremia by B. tribocorum and B. birtlesii (Mitchell &
Minnick, 1995)
HbpB–HbpE A family of hemin-binding proteins, some members are essential for intraerythrocytic bacteremia by
B. tribocorum and B. birtlesii (Carroll et al., 2000; Minnick et al., 2003b)
HutA Hemin receptor, essential for intraerythrocytic bacteremia by B. tribocorum and B. birtlesii (Parrow et al.,
2009)
Omp43 Putative adhesin, recombinant Omp43 binds ECs (Burgess & Anderson, 1998)
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in cats appears mainly subclinical, may last for several
months or even years, and is manifested by the presence
of bacteria in the blood within the erythrocytes (Kordick
& Breitschwerdt, 1995). As an example, one naturally
B. henselae-infected cat had > 10 000 CFU of B. henselae
per milliliter of blood at day 0 of a longitudinal 2-year
study of infection under laboratory conditions (Abbott
et al., 1997). The bacteremia gradually declined and the
cat became culture negative 5 months later. However,
bacteremia was again detected 2 months later. For the
rest of the longitudinal infection study, the cat became
cyclically culture negative at 2-month intervals with
the abacteremic periods lasting, on average, for 2 months.
The anti-B. henselae antibody titer of the cat remained
stable throughout the whole 2-year follow-up (Abbott
et al., 1997). The cyclical nature of bacteremia appears
common for Bartonella spp. infections in their natural
reservoir hosts (Fig. 2). The location, designated as the
primary niche in the B. tribocorum-rat infection model
(Schu¨lein et al., 2001), where the bacteria reside during
the nonbacteremic state remains unknown and is one of
the most significant open questions in the field (see Iden-
tity of the primary niche). It has been shown that cats do
not become bacteremic during housing with highly bac-
teremic cats, but fleas that have been feeding on highly
bacteremic cats efficiently transmit B. henselae infection
to uninfected cats (Chomel et al., 1996; Abbott et al.,
1997). These findings clearly indicate the importance of
arthropod vector for the transmission of B. henselae, and
this most likely applies to most species of Bartonella spp.
(Fig. 1). In support of the natural transmission route of
B. henselae, five pathogen-free cats that were inoculated
intradermally with 1 9 106 CFU of plate-grown B. henselae
Table 2. The most significant open questions of the Bartonella spp. research field
(1) Adaptation to specific arthropod vectors and mammalian reservoir hosts seems to be a common strategy of Bartonella spp. pathogenesis.
What determines the arthropod specificity and the mode of transmission, and what are the bacterial factors involved in the arthropod
infection and transmission?
(2) Which cellular or acellular habitat constitute the primary niche of the reservoir host? During passage through the primary niche, how are
Bartonella spp. programmed to become competent for the subsequent erythrocyte invasion? What determines the peculiar periodicity of
bacterial release from the primary niche into the bloodstream?
(3) Immunosuppression appears as a prerequisite for vascular tumor formation by B. henselae, B. quintana, and B. bacilliformis in human.
What does this commonly used phrase ‘immunosuppression’ actually mean at the molecular level at the interface of host–pathogen
interaction?
(4) What is the nature of bacterial factor(s) that mediate the angiogenic activation of ECs? In contrast to the autocrine and paracrine route of
pro-angiogenic factor release, what is the contribution of the direct bacterial activation of EC proliferation in vascular deformations? Can we
establish an animal model for Bartonella spp.-triggered vascular deformations?
(5) What is the exact contribution of VirB/VirD4-T4SS in Bartonella spp.-triggered vascular deformations? What is the exact contribution of
VirB/VirD4-T4SS in the reservoir host infections? How do the individual Bartonella-translocated effector proteins (Beps) contribute to the
subversion of EC functions? Are there other cell types that are targeted by VirB/VirD4-T4SS and its effectors? How are Bep expression, timing
of Bep translocation, quantities of the translocated Beps, and composition of the Bep pool that is received by a given cell type regulated?
(6) Are Bartonella spp. infections an emerging zoonotic threat to humans? How well Bartonella spp. respond to commonly used antibiotics
and can it be envisioned that the efficient capacity of these bacteria for conjugative spread of plasmids will create significant clinical problems
in the future? How can we transfer the basic research findings into clinical practice?
Fig. 2. Progression of the chronic and relapsing Bartonella spp.
intraerythrocytic bacteremia in a mammalian reservoir host. After initial
inoculation, for example, of bacteria in arthropod feces that are
superficially scratched into the skin, the bacteria reside and persist in
the still-enigmatic primary niche (lag phase). Bacteremia is initiated
several days postinoculation by a rapid appearance of high numbers of
bacteria in the bloodstream (arrow 1), with bacteria binding to and
subsequently invading the erythrocytes. Intraerythrocytic bacteria
replicate until reaching a steady number, which is maintained for the
remaining life span of the infected erythrocytes. The primary niche is
believed to seed additional erythrocyte infection waves at regular
intervals (arrows 2–4) until a specific antibody response clears the
infection by blocking the erythrocyte invasion. However, bacteremia
may peak (arrow 5) after prolonged periods (weeks to months) of
abacteremia (dormant phase) presumably by clonal expansion of
antigenic and/or phase variants, which are seeded into the bloodstream
from the primary niche. During the long-lasting intraerythrocytic
bacteremia, efficient transmission of the intraerythrocytic pathogen to
other susceptible hosts is mediated by blood-sucking arthropods, such
as fleas and lice. Details are described in the text (see Progression of
Bartonella spp. infection in the reservoir mammalian host).
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became bacteremic at 9 days postinoculation, which was
followed by seroconversion (Abbott et al., 1997).
Similar to the B. henselae-cat infection model, B. triboco-
rum infection in its natural reservoir host rat (Heller et al.,
1998) appears mainly asymptomatic. Following intrave-
nous inoculation with 3.5 9 107 CFU of agar plate–
grown B. tribocorum (Schu¨lein et al., 2001), the bacteria
appeared unable of entering the erythrocytes and instead
were cleared from the circulation within hours postinocu-
lation and remained below detectable levels (viability
plating and flow cytometry/confocal microscopy–based
detection) for about 4 days. The niche that supports rep-
lication of B. tribocorum during this time or with analogy
the niche that supports replication of B. henselae during
the abacteremic phases in cat (Abbott et al., 1997) has
not been identified experimentally. It has been speculated,
mainly because of the marked tropism of Bartonella spp.
for ECs that is especially prominent for example, in the
Carrion’s disease (Maguin˜a et al., 2009) and their prox-
imity to the bloodstream, that ECs are an important con-
stituent of the primary niche (Dehio, 2005). However, the
primary niche may also comprise other cell types that is,
the migratory cells, such as dendritic cells (DCs), which
might assist the passage of bacteria from the site of inoc-
ulation (e.g. bacteria in arthropod feces that are superfi-
cially scratched into the skin) into the circulation (see
Proposal of DCs and the draining lymph nodes). Typi-
cally, on day 5 postinoculation, high numbers of bacteria
(~ 106–107 per milliliter of blood) are detectable in the
blood (Schu¨lein et al., 2001). Presumably, this first wave
of bacteremia represents the release of bacteria from the
primary niche. The bacteria attach, invade, and replicate
inside the erythrocytes until a plateau of approximately
eight bacteria per infected erythrocyte is reached around
day 14 postinoculation, although some infected erythro-
cytes may contain up to 15 intracellular bacteria. Thereaf-
ter, the number of intracellular bacteria remains static for
the remaining life span of the infected erythrocytes. The
life span of the infected erythrocytes is indistinguishable
from that of uninfected erythrocytes. The intraerythrocy-
tic bacteremia caused by B. tribocorum in rats drops
below detectable levels after approximately 10 weeks
(Schu¨lein et al., 2001). Prior to that, the numbers of via-
ble bacteria in the blood decline, however, not in a steady
manner. Instead, the decline is intercepted by peaks of
bacteremia, that is, higher fraction of circulating erythro-
cytes that have been infected, which appear at intervals of
3–6 days (Fig. 2). It is currently believed that these waves
are because of bacteria that have been synchronously
released from the still-enigmatic primary niche. It
remains unknown what determines this periodicity.
The main host immune surveillance mechanism that
eventually clears the infection appears to be mediated by
antibodies, at least based on studies in the natural B.
grahamii mouse infection model (Koesling et al., 2001).
In immunocompetent C57BL/6 mice, the B. grahamii
bacteremia was transient with an average duration of
9 weeks and induced a strong antibody response. In con-
trast, bacteremia persisted in immunocompromised
B-cell-deficient (C57BL/6-Igh/) or B- and T-cell-defi-
cient mice (C57BL/6-Rag1/). Immune serum transfer
beginning with day 6 postinfection from the immuno-
competent mice to B-cell-deficient mice that are unable
to produce immunoglobulins converted the persistent
bacteremia to a transient course indistinguishable from
that of immunocompetent animals (Koesling et al., 2001).
These data demonstrate an essential role of specific anti-
bodies in abrogating the intraerythrocytic bacteremia of
B. grahamii in mice, and this may also apply to other
species of Bartonella spp. Indeed, it has been reported
that cats that have cleared an earlier B. henselae infection
caused by the same B. henselae strain do not become
bacteremic (Abbott et al., 1997).
Transmission from the arthropod vector
The long-lasting intraerythrocytic infection strategy as
revealed by studies with several natural reservoir host
infection models such as rhesus macaque-B. quintana
(Zhang et al., 2004), cat-B. henselae (Chomel et al., 1996;
Regnery et al., 1996; Abbott et al., 1997; Guptill et al.,
1997; O’Reilly et al., 1999), rat-B. tribocorum (Schu¨lein
et al., 2001), mouse-B. grahamii (Koesling et al., 2001),
dog-Bartonella vinsonii Berkhoffii (Pappalardo et al.,
2000, 2001), and mouse-Bartonella birtlesii (Boulouis
et al., 2001; Marignac et al., 2010) is probably a specific
adaptation mechanism to the transmission by blood-suck-
ing arthropods and is presumably shared by most species
of Bartonella spp. The only known exception to this rule
is B. bacilliformis, which may trigger massive hemolysis of
the colonized human erythrocytes, giving rise to an often-
fatal hemolytic anemia (Maguin˜a et al., 2009). When an
infected arthropod comes into contact with an uninfected
reservoir host, direct blood contact or intra-/subcutane-
ous inoculation through arthropod bite might take place,
but the highest bacterial numbers are expected to be
inoculated via arthropod feces (Chomel et al., 2009b).
Most likely, intra-/subcutaneous inoculation by feces
takes place via superficial scratching and tissue trauma of
the skin. It has been reported that viable B. quintana are
present in feces of experimentally infected body lice up to
the death of the lice (about 35 days) (Fournier et al.,
2001). In another study, viable B. henselae was detected
in the feces of a cat flea 9 days after the flea had been fed
with a concentration of 1 9 105 CFU mL1 of B. hense-
lae in blood (Higgins et al., 1996).
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Molecular mechanisms of Bartonella spp.
pathogenesis
Long-lasting bacteremic infections suggest a specific adap-
tation of Bartonella spp. to the corresponding reservoir
host and circumvention of its immune responses. This
chapter will follow the infection cycle of Bartonella spp.
in a reservoir host, which starts with an intradermal inoc-
ulation (bacteria in arthropod feces that are superficially
scratched into the skin) and ends up with the pathogen
exit by the blood-sucking arthropod. The current knowl-
edge of bacterial countermeasures against the mammalian
immune response will be presented for each critical step
of the pathogenesis (Fig. 3).
Evasion of innate immune responses
Strategies utilized by Bartonella spp. against
professional phagocytes
Means to affect recognition by pattern recognition recep-
tors (PRRs)
Professional phagocytes such as tissue-resident macro-
phages and DCs are both sentinels and the first line of
defense against infection. Right after host entry and in
the absence of an adaptive immune response, PRRs on
the professional phagocytes are expected to play a major
role in the recognition of Bartonella spp.. Lipopolysaccha-
ride (LPS) is an essential outer membrane component in
Gram-negative bacteria. LPS and in particular its lipid A
portion are recognized by PRR-subgroup Toll-like recep-
tors (TLRs), mainly TLR4 together with CD14, which
evokes the secretion of pro-inflammatory cytokines and
subsequent recruitment of other inflammatory cells to the
point of pathogen entry (Miller et al., 2005) (Fig. 4). The
apparent lack of LPS-associated septic shock in Bartonella
spp. bacteremia in later stages of the infection indicates
that the LPS of Bartonella spp. might be only weakly rec-
ognized by TLR4. Indeed, it has been reported that the
purified LPS from B. henselae is 1000–10 000-fold less
active than the purified LPS from Salmonella enterica sv
Friedenau in activating TLR4 signaling (Za¨hringer et al.,
2004). Structural analysis of B. henselae LPS revealed
unusual features that might explain the weak TLR4 acti-
vation (Fig. 4), including a rare penta-acylated GlcN3N
disaccharide bisphosphate as the lipid A, an uncommon
hydroxylated long-chain fatty acid linked to the lipid A,
and a small inner core composed of an a-(2?4)-linked
3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) disaccharide
with one glucose residue attached (Za¨hringer et al.,
2004). It is known that enterobacterial lipid A with a
reduced number of fatty acids (normally hexa-acylated),
such as a penta-acylated lipid A lacking a secondary
myristic acid (14:0) residue in waaN mutant of Salmo-
nella enterica sv. Typhimurium, is significantly less toxic
in vivo (Khan et al., 1998). Moreover, similar to the LPS
of B. henselae, LPS of Legionella pneumophila that causes
chronic infections has an uncommon long-chain fatty
acid linked to the lipid A, and it has been reported that
this modification augments TLR4/CD14 activation owing
to the lack of LPS–CD14 interaction (Neumeister et al.,
1998). It has also been reported that purified LPS of
B. quintana does not induce the production of
Fig. 3. Schematic representation of the critical steps of Bartonella spp. pathogenesis in a mammalian reservoir host. The infection cycle initiates
typically by bacteria in arthropod feces that are superficially scratched into the skin and terminates by pathogen exit by the blood-sucking
arthropod. Details are described in the text (see Molecular mechanisms of Bartonella spp. pathogenesis).
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pro-inflammatory cytokines in human monocytes (Popa
et al., 2007). LPS of B. quintana even appears to be an
efficient antagonist of TLR4 activation because it was able
to inhibit Escherichia coli LPS-mediated release of tumor
necrosis factor a (TNF-a), interleukin-1b (IL-1), and
interleukin-6 (IL-6) by human monocytes at ratios rang-
ing from 1000 : 1 to 10 : 1 (B. quintana LPS: E. coli LPS)
(Popa et al., 2007). Because of this property, the LPS of
B. quintana has been evaluated as a potential therapeutic
tool to block TLR4 signaling in rheumatoid arthritis with
promising results (Abdollahi-Roodsaz et al., 2007). The
chemically distinct form of LPS appears important for
Bartonella spp. to establish the long-lasting bacteremia
without symptoms of septic shock. Although not yet
Fig. 4. Bartonella henselae produces a LPS of very low endotoxicity. Recognition of bacterial LPS by the innate immune system elicits strong pro-
inflammatory responses. LPS-mediated activation of mammalian cells involves the interaction of LPS with LPS-binding protein (LBP) and
subsequently with TLR4/CD14/MD2 complex. Proposed structure of the lipid A of B. henselae (LPS) and comparison to corresponding structures
of Escherichia coli and Legionella pneumophila LPS. LPS of B. henselae has weak endotoxic activity, possibly due to the (1) penta-acylation of the
GlcN3N disaccharide bisphosphate, (2) presence of an uncommon hydroxylated long-chain fatty acid linked to the lipid A, and (3) presence of a
small inner core (not shown in the figure) composed of an a-(2?4)-linked 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) disaccharide with one
glucose residue attached. Details are described in the text [see Means to affect recognition by pattern recognition receptors (PRRs)].
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experimentally proven, the lack of TLR4 activation might
also be important right after the host entry to interfere
with the pathogen recognition by professional phagocytes.
Some species of Bartonella spp. such as Bartonella
schoenbuchensis (Dehio et al., 2004), B. bacilliformis
(Benson et al., 1986; Scherer et al., 1993), and Bartonella
clarridgeiae (Kordick et al., 1997; Sander et al., 2000b)
express flagella, polymeric rod-like structures that are
important for bacterial motility. However, these structures
may extend several micrometers from the bacterial outer
membrane and thereby serve as ideal pathogen-associated
molecular patterns for PRRs. TLR5 recognizes an evolu-
tionarily conserved site on bacterial flagellin, the main
constituent of flagella (Hayashi et al., 2001; Smith et al.,
2003). It has been reported that the flagellated B. bacilli-
formis do not induce the typical flagellin-induced and
TLR5-dependent activation of NF-jB (Andersen-Nissen
et al., 2005). The flagellin of B. bacilliformis contains
amino acid changes, which allow evasion of TLR5 recog-
nition but at the same still preserve bacterial motility
(Andersen-Nissen et al., 2005). Although not yet experi-
mentally proven, the high sequence similarity of
B. clarridgeiae flagellin to B. bacilliformis flagellin (Andersen-
Nissen et al., 2005) indicates that also this member of
Bartonella spp. might escape from TLR5-mediated flagel-
lin recognition. Despite the efficient means to evade
TLR4 and TLR5 recognition, it has been reported that
infection of J774 mouse macrophages by B. henselae
in vitro is followed by the release of high concentrations
of IL-1b and IL-6 in addition to TNF-a, a potent enhan-
cer of macrophage bactericidal activities (Musso et al.,
2001). It remains to be studied how Bartonella spp. bene-
fit in vivo from their apparently efficient means to evade
from TLR4 and TLR5 recognition.
Means to affect effector functions of professional
phagocytes
Macrophages. Bartonella henselae strain Marseille has been
reported to delay its lysosomal targeting and destruction
in J774A.1 mouse macrophages at least when compared
in parallel with Listeria innocua (Kyme et al., 2005). In
another independent study, it was shown that B. henselae
strain Houston-1 enters and stays viable at least for up to
8 h in J774 mouse macrophages (Musso et al., 2001).
Also, B. quintana has been reported to enter THP-1
human macrophages, although to a lesser extent than
B. henselae (Schulte et al., 2006). It appears that B. hense-
lae enters the macrophage in a unique vacuolar compart-
ment, Bartonella-containing vacuole (BCV), which lacks
the typical early endocytic marker proteins such as trans-
ferrin receptor and early endosome antigen 1 (Kyme
et al., 2005). However, in later stages of infection (around
24 h), BCVs appear to fuse with lysosomes and bacteria
get ultimately destroyed. The unusual trafficking and
delayed lysosomal destruction of B. henselae is dependent
on bacterial viability as heat-killed bacteria were detected
in a LAMP1-positive compartment already 2 h postinfec-
tion, which typically took 24 h with viable bacteria
(Kyme et al., 2005). Based on this observation, the
authors enriched transposon mutants that were located in
a lysosome-fused compartment 2 h postinfection and
report identification of four genes encoding for (1) puta-
tive virulence-associated protein VapA5, (2) putative
heme-binding protein HbpD, (3) D-serine/D-alanine/gly-
cine transport protein CycA, and (4) one protein without
any known function. The detailed molecular functions of
these proteins that possible regulate BCV trafficking have
not been studied nor it is known whether the delayed
lysosomal targeting and destruction could be beneficial
for Bartonella spp. in vivo. In fact, it has been reported
that B. henselae produces a Bartonella adhesin A (BadA),
a trimeric autotransporter adhesin (TAA), which is a
potent inhibitor of phagocytic uptake of B. henselae in
J774A.1 mouse macrophages (Riess et al., 2004).
Polymorphonuclear leukocytes. Polymorphonuclear leuko-
cytes (PMNs) are actively recruited to the sites of micro-
bial infection (Borregaard, 2010). Bartonella spp. have
means to escape from professional phagocyte recognition
[see Means to affect recognition by pattern recognition
receptors (PRRs)], but the detected pro-inflammatory
cytokine responses under in vitro conditions (Musso
et al., 2001) indicate that PMNs become a significant
threat for Bartonella spp. right after the host entry. There
exists one report, which indicates that B. henselae is able
to inhibit the production of reactive oxygen species that
is, the oxidative burst in PMNs, which is one of the most
important antimicrobial effector mechanisms of PMNs
(Fumarola et al., 1994). This study has not been evalu-
ated further nor was the bacterial factor(s) identified, but
the inhibition of the oxidative burst potentially represents
one additional survival strategy for Bartonella spp. in the
reservoir host.
Dendritic cells. Upon exposure to microbial pathogens in
peripheral tissues such as inflamed skin, DCs migrate to
lymph nodes and undergo maturation into potent immu-
nostimulatory cells, especially to evoke a clonal expansion
of antibody-producing B cells (Martı´n-Fontecha et al.,
2009). In the context of an incidental host infection, it
has been reported that immature human monocyte-
derived DCs readily ingest B. henselae in vitro in the
absence of opsonins (Vermi et al., 2006). This appears
as a strong stimulus for DC maturation because it
induced the expression of CD83 and CCR7/CD197 and
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the upregulation of HLA-DR and CD86 to levels compa-
rable with those obtained with LPS of S. enterica sv
Friedenau (Vermi et al., 2006). Moreover, DCs that were
matured by incubation with B. henselae were able to
induce the proliferation of allogeneic T lymphocytes at
levels that were comparable to those obtained with LPS
(S. enterica sv Friedenau)-matured DCs (Vermi et al.,
2006). The infection also induced the production of high
levels of CXCL13 (Vermi et al., 2006), which is an extre-
mely potent chemoattractant for B lymphocytes (Gunn
et al., 1998). In part, the data appear to explain the
unusually high content of B lymphocytes in swollen
lymph nodes of patients with cat scratch disease (CSD).
Activation of DCs was shown to be dependent on TLR2
(Vermi et al., 2006) and thereby most likely on the recog-
nition of bacterial lipoproteins, which is in accordance
with the data indicating that LPS and flagellin of Barto-
nella spp. are weak activators of TLR4 (Za¨hringer et al.,
2004) and TLR5 (Andersen-Nissen et al., 2005), respec-
tively [see Means to affect recognition by pattern recog-
nition receptors (PRRs)]. Lipid modification of the
N-terminal Cys residue (N-acyl-S-diacylglyceryl-Cys) is
an essential, ubiquitous, and unique bacterial post-trans-
lational modification. Such a modification allows anchor-
ing of even highly hydrophilic proteins to the membrane,
which carry out a variety of functions important for bac-
teria, including pathogenesis (Kovacs-Simon et al., 2011).
TLR1, 2, and 4 are known to cooperate in the recognition
of bacterial lipoproteins to elicit an antimicrobial
response (Kawai & Akira, 2005). It has also been reported
that B. grahamii induces the maturation of bone-marrow-
derived conventional DCs isolated from its natural reser-
voir host mouse in a similar fashion to parallel-analyzed
B. henselae (Kunz et al., 2008). Bone-marrow-derived
plasmacytoid DCs were also shown to get activated using
interferon-a and interferon-b (IFN-a/b) secretion as the
readout, but interestingly B. grahamii induced more IFN-
a/b secretion than B. henselae (Kunz et al., 2008). The
authors substantiated this in vitro finding by analyzing
the development of Bartonella-induced lymphadenopathy
in type I interferon receptor (IFNAR1)-deficient mice.
With wild-type background, it had already been observed
that intradermal inoculation of B. grahamii induced only
a mild and short-lived lymphadenopathy (as quantified
by weighting of the lymph nodes) as compared to pro-
longed and enhanced swelling of lymph nodes with B.
henselae inoculation (Vermi et al., 2006). As expected, IF-
NAR1-deficient mice developed significantly larger lymph
nodes after B. grahamii infection than the respective wild-
type controls. Similar trend was observed with B. henselae
infection, although the difference was not significant
between the wild-type and IFNAR1-deficient mice (Kunz
et al., 2008). These findings are compatible with a model
where high IFN-a/b production induced by B. grahamii
in its natural reservoir host mouse inhibits the develop-
ment of lymphadenopathy, possibly via inhibition of the
proliferation of B lymphocytes, which is typically pro-
nounced in the swollen lymph nodes of patients with
CSD (Vermi et al., 2006). It can be speculated that in the
context of a reservoir host infection, B. grahamii and pos-
sibly other species of Bartonella spp., selectively overacti-
vate one cytokine response of DCs (Monroe et al., 2010).
The final outcome is the inhibition of B-cell response and
thereby antibody response and overall attenuation of host
immune surveillance, which in the end allow the estab-
lishment of a chronic intraerythrocytic bacteremia.
Means to affect complement activation
The complement system plays a major role in resistance
against microbial infections both in the circulation and in
the peripheral tissues either directly or via professional
phagocytes. It can be activated (1) by antigen–antibody
complexes (classical pathway), (2) by certain carbohy-
drates (lectin pathway), or (3) by a variety of pathogen
surface structures (alternative pathway) (Rautemaa &
Meri, 1999). Resistance to host complement appears to be
an important pathogenic mechanism in bacteria that
cause acute and fast progressing infections such as Strep-
tococcus pyogenes (Akesson et al., 1996) and also in bacte-
ria that cause chronic and persistent infections such as
Borrelia burgdorferi (Hellwage et al., 2001). It has been
reported that B. quintana is resistant to direct comple-
ment-mediated killing in a system where high-titered
anti-B. quintana rabbit serum and nonimmune serum
were studied with guinea pig complement (Myers & Wis-
seman, 1978). However, in another study, it was reported
that B. quintana outer membrane extract induced the
activation of rabbit serum complement (Hollingdale
et al., 1980). In this study (Hollingdale et al., 1980), the
authors did not address bacterial mechanisms to inhibit
complement activation. One study has focused on
complement resistance mechanisms of B. henselae (Rodri-
guez-Barradas et al., 1995). The authors reported a con-
centration- and time-dependent bactericidal effect of
nonimmune human serum to B. henselae Houston-1. In
their study, 20% nonimmune human serum was sufficient
to kill more than 99% of the organisms after 30-min
incubation. The alternative pathway of the complement
system appeared to be mainly involved, although the
authors also detected the activation of classical pathway
despite the apparent lack of opsonizing anti-B. henselae
antibodies (Rodriguez-Barradas et al., 1995). The impor-
tance and even the presence of complement resistance
mechanisms in Bartonella spp. remain elusive, primarily
by the lack of significant primary studies. It has been
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argued that these studies should be conducted in the con-
text of natural reservoir host infections (Vayssier-Taussat
et al., 2009) and potentially as one molecular mechanism
of host specificity. This rationale arises from the observa-
tion that B. burgdorferi sensu lato differs in its sensitivity
to complement from different vertebrate species (Kurten-
bach et al., 1998).
Penetration of tissues
Interactions with the extracellular matrix
In principle, tissue penetration from the primary site of
inoculation could be achieved with analogy to secreted or
surface-associated proteases such as SpeB of S. pyogenes,
which directly degrades extracellular matrix components
and also activates host matrix metalloproteinases (Ras-
mussen & Bjo¨rck, 2002). However, there are no reports
available that describe well-defined secreted or surface-
associated proteases in Bartonella spp. Binding of extra-
cellular matrix components per se appears to be an
important feature of Bartonella spp. In some studies, it
has been discussed in the context of open wound infec-
tions as a potent mechanism to circumvent cleansing
(Dabo et al., 2006a, b), although the major interest on
extracellular matrix–Bartonella spp. interaction has
focused on endothelial cell adhesion in later blood stages
of the infection (Riess et al., 2004; Mu¨ller et al., 2011).
BadA of B. henselae has been reported to bind vitro-
nectin, laminin, hyaluronic acid, fibronectin (both cellular
and plasma forms), and collagens I, II, and IV (Riess
et al., 2004; Mu¨ller et al., 2011). The expression of BadA
varies in primary isolates of B. henselae and is sometimes
absent indicating phase variation (Riess et al., 2007).
Bartonella henselae has also been reported to bind
collagens IX and X (Dabo et al., 2006a, b), and outer
membrane protein (OMP) Pap31 appears to mediate
BadA-independent binding to fibronectin (Dabo et al.,
2006a, b). Bartonella quintana variably express four differ-
ent but highly conserved adhesins, VompA–D, where
VompA and C were initially identified to bind collagen
IV (Zhang et al., 2004). The recent data indicate that the
ligand repertoire of Vomps might also contain vitronec-
tin, laminin, hyaluronic acid, fibronectin (both cellular
and plasma forms), and collagens I and II (Mu¨ller et al.,
2011). In the context of Bartonella spp.–reservoir host
interaction, it is significant that intradermally inoculated
Vomp-null mutant was unable to establish bacteremia in
a rhesus macaque animal model of B. quintana infection
(Zhang et al., 2004; MacKichan et al., 2008). Bartonella
vinsonii ssp. arupensis also appears to express a large
OMP, BrpA, with similarity to Vomps and BadA (Gil-
more et al., 2005), but the molecular function of this
protein has remained elusive. Bartonella bacilliformis
appears to also contain three variable but still functionally
uncharacterized brp genes (Kaiser et al., 2011). In conclu-
sion, it appears that binding to ECM is a conserved
molecular feature in Bartonella spp. and it may play an
important role also in the early stages of infection. How-
ever, based on the current knowledge, it seems unlikely
that the tissue penetration of Bartonella spp. would rely
on ECM binding and subsequent degradation similar to,
for example, S. pyogenes tissue invasion (Rasmussen &
Bjo¨rck, 2002).
Interactions with fibroblasts and epithelial cells
Skin is rich of dermal fibroblasts. They produce and orga-
nize the extracellular matrix (~ 70% of the dermis is col-
lagen), actively communicate with each other and other
cell types such as epithelial cells of the epidermis and cells
of the hematopoietic origin of dermis/epidermis, and
therefore play a crucial role in the regulation of skin
physiology (Sorrell & Caplan, 2004). Early work on B. ba-
cilliformis indicated that the bacterium is able to attach to
and invade both human fibroblasts and epithelial cells
(Hill et al., 1992). The process appeared to require actin
remodeling because cytochalasin D, a cell-permeable
inhibitor of actin polymerization, inhibited the invasion
(Hill et al., 1992). Moreover, it was shown that genistein,
a tyrosine kinase inhibitor, decreased the invasion of the
epithelial cells by B. bacilliformis (Williams-Bouyer & Hill,
1999), which indicate that the cells were actively engaged
in the invasion process. Interestingly, exposure of epithe-
lial cell monolayers to anti-a5 and anti-b1 integrin
monoclonal antibodies decreased the invasion of the cells
by B. bacilliformis, suggesting a possible role of a5b1-
integrin (fibronectin receptor) in the bacterial uptake
(Williams-Bouyer & Hill, 1999). Integrins have also been
implicated in the adhesion of B. henselae to fibroblast-like
mouse embryonic stem cell line GD25 (Riess et al., 2004).
The bacteria adhered more strongly to GD25-derivative
(GD25-b1A) cells that express b1-integrins than to the
parental b1-integrin-deficient GD25 cells. The binding
was inhibited by anti-fibronectin antibodies, which indi-
cates that fibronectin is somehow involved in the process
(Riess et al., 2004). Integrins also appear important medi-
ators of B. henselae–EC interaction (see Endothelial cell
adhesion and subsequent invasion, B. henselae). Bartonella
henselae can also invade epithelial cells (Batterman et al.,
1995; Zbinden et al., 1995; Schulte et al., 2006;
Truttmann et al., 2011a), and this process may lead into
uptake of a large bacterial aggregate (Truttmann et al.,
2011a), which resembles the invasome-mediated uptake of
B. henselae into human ECs (Dehio et al., 1997). In conclu-
sion, it appears that B. bacilliformis and B. henselae readily
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invade fibroblasts and epithelial cells in vitro. There are no
reports available that link this ability to Bartonella spp.
pathophysiology in vivo. However, it appears impossible to
invade and penetrate skin without encountering fibroblasts
and epithelial cells. Perhaps these cells provide a transient
and immunologically privileged niche for Bartonella spp.
right after the host entry at the skin. Otherwise, Bartonella
spp. should be able to subvert its potent capacity to invade
fibroblasts and epithelial cells (Batterman et al., 1995;
Zbinden et al., 1995; Schulte et al., 2006; Truttmann et al.,
2011a), which could in principle be achieved by phase
variation of surface adhesin(s) like in the case of BadA-
mediated adhesion of B. henselae to human ECs (Riess
et al., 2007).
Invasion into the bloodstream
In previous chapters, we have outlined molecular mecha-
nisms how Bartonella spp. may evade host innate immunity
right after host entry. How Bartonella spp. are able to gain
access to the bloodstream once intra-/subcutaneously inoc-
ulated and what is the identity of the primary niche? We
assume that in nature the direct blood infection via arthro-
pod bite is not a very realistic scenario and if so, the bacteria
appear unable to infect erythrocytes based on the rat-
B. tribocorum (Schu¨lein et al., 2001) andmouse-B. grahamii
(Koesling et al., 2001) natural reservoir host models. As an
example, after intravenous inoculation of 3.5 9 107 CFU
bacteria, B. tribocorum was rapidly cleared from the circula-
tion, and only after several days, the bacteria reappeared in
the blood from the still-enigmatic primary niche and
invaded erythrocytes (Schu¨lein et al., 2001).
Identity of the primary niche
Several observations in natural reservoir hosts indicate that
Bartonella spp. reside in a cellular or acellular compartment,
persist, and are periodically seeded into the circulation
(Fig. 2). As an example, one naturally B. henselae-infected
cat had > 10 000 CFU of B. henselae per milliliter of blood
at day 0 of a longitudinal 2-year study of infection under lab-
oratory conditions (Abbott et al., 1997). The bacteremia
gradually declined and the cat became culture negative
5 months later. However, bacteremia was again detected
2 months later. For the rest of the longitudinal infection
study, the cat became cyclically culture negative at 2-month
intervals with the abacteremic period lasting, on average, for
2 months. Experimental transmission of B. henselae to spe-
cific pathogen-free cats via fleas removed from bacteremic
cattery cats largely reproduced the above data (Chomel
et al., 1996). It took on average 2 weeks until the bacteremia
was detected, and when bacteria appeared in the blood, the
numbers were immediately high (104–106 CFU mL1).
One kitten became culture negative after approximately
4 months of bacteremia, but had three relapses of bactere-
mia during the rest of the 1-year observation period (Cho-
mel et al., 1996). Similar relapsing bacteremia has been
observed in the rhesus macaque-B. quintana model where
bacteria were inoculated intradermally to mimic the natural
infection route and it took 12 days until the bacteremia
peaked (Zhang et al., 2004). Indeed, the infection route
appears to be of central importance to make physiologically
significant conclusions. In the mouse-B. birtlesii model
(Marignac et al., 2010), bacteremia was detected as early as
day 3 postinoculation when Balb/c mice were injected intra-
dermally compared with day 7 postinoculation with the
subcutaneous route. The peak of bacteremia for the intra-
dermal group was reached at day 13 postinoculation and
was roughly 10 times lower than the bacteremia peak for the
subcutaneous group (day 23 postinoculation). The most sig-
nificant finding of this study was, however, that the intrader-
mally inoculated group entered the relapsing bacteremia
phase and subcutaneously inoculated group did not, at least
in the time frame of the reported experiment (Marignac
et al., 2010).
Hypothesis of the endothelial cells of the vascular wall
The most widely appreciated primary niche hypothesis is
the vascular wall, in more particular an intravacuolar
compartment in an EC (Dehio, 2005). This is primarily
based on the disease pathologies of B. quintana and B. ba-
cilliformis infections in their natural reservoir host
human, in addition to the wealth of information available
for B. henselae–human EC interaction. Bartonella bacilli-
formis is a deadly pathogen that causes a biphasic Car-
rion’s disease in endemic areas of the Andes. The acute
phase, called Oroya fever, is characterized by an intra-
erythrocytic bacteremia that results in an often-fatal
hemolytic anemia. The subsequent chronic phase, known
as verruga peruana, manifests in vascular tumors that
result from the proliferation of ECs where B. bacilliformis
may form large cytoplasmic inclusions (Maguin˜a et al.,
2009). A similar tropism for human erythrocytes is
observed for B. quintana (Rolain et al., 2002; Rolain
et al., 2003c). However, the bacteria do not appear hemo-
lytic, and the development of vascular deformations/
tumors (BA) requires that the human host is immuno-
compromised as an example suffering from AIDS (Ma-
guin˜a et al., 2009). EC invasion by B. bacilliformis has
been reproduced in vitro by several investigators (Garcia
et al., 1990, 1992; Hill et al., 1992; Verma et al., 2000,
2001; Verma & Ihler, 2002; Cerimele et al., 2003). EC
invasion by B. quintana appears more elusive in vitro,
although the bacterium has been reported to adhere to
and invade human ECs in vitro (Brouqui & Raoult, 1996;
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Palmari et al., 1996; Mu¨ller et al., 2011) and potentially
affect significant cellular processes such as apoptosis (Sch-
mid et al., 2006) and proliferation (Palmari et al., 1996).
Apart from B. quintana and B. bacilliformis, in vitro stud-
ies of Bartonella spp. interaction with their reservoir host
ECs have largely been neglected nor has such interaction
ever been described in vivo. Only significant exception is
one recent in vitro study where effects of B. henselae on
human and feline macro- and microvascular ECs were
compared (Berrich et al., 2011). The biological readouts
with skin microvascular ECs clearly demonstrate that B.
henselae increases the cell migration of human but not
feline ECs in wound healing assays and that B. henselae
strongly induces vascular endothelial growth factor
(VEGF) secretion by human but not feline ECs (Berrich
et al., 2011). These results may explain the reduced path-
ogenic potential of B. henselae on cats as compared to
humans. However, in the absence of direct cell adhesion
and invasion data, the results appear inconclusive to
answer the burning question if ECs truly constitute the
primary niche of B. henselae in the cat. Further in vitro
and in vivo studies in different mammals such as mouse
or a rat with their respective Bartonella spp. colonizers
are urgently needed. Conceptually, the EC primary niche
hypothesis appears logical in the intravenous reservoir
host models (Koesling et al., 2001; Schu¨lein et al., 2001).
However, can it be applied to the more natural
intradermal infection routes? Onset of the intraerythr-
ocytic bacteremia after intradermal inoculation is pre-
ceded by a significant lag (days–weeks) of abacteremia
(Chomel et al., 1996; Abbott et al., 1997; Zhang et al.,
2004; Marignac et al., 2010), which indicates that the bac-
teria should enter the ECs from the apical surface, repli-
cate, persist, and be synchronously seeded into the
bloodstream.
Hypothesis of the circulatory hematopoietic stem cells
ECs have a low proliferative potential, and therefore, vas-
cular repair requires additional support. Vascular repair
and neoangiogenesis are mediated, at least in part, by
hematopoietic stem cells (HSCs) (Urbich & Dimmeler,
2004). It has been reported that B. henselae strain
ATCC49882 adheres to and invades human HSCs, that is,
CD133-positive cells that were enriched from peripheral
blood mononuclear cells (Salvatore et al., 2008). CD133
is expressed on HSCs but is absent on mature ECs (Urb-
ich & Dimmeler, 2004). This is a significant finding
because circulating HSCs appear inherently resistant to
invasion by a variety of microbial pathogens (Kolb-
Ma¨urer et al., 2002). It was proposed that HSCs could
carry B. henselae to peripheral tissues, in particular, to
endothelium of microcirculation where vasoproliferative
disorders initiate (Salvatore et al., 2008). Although this
might be the cellular basis of B. henselae-induced BA/peli-
osis in the incidental host human, it has also been pro-
posed that HSCs might constitute the primary niche of
Bartonella spp. in their respective reservoir hosts (Ma¨ndle
et al., 2005). This argument was based on an observation
that intracellular B. henselae were detected in human ery-
throid cells that were induced from HSCs, that is, CD34-
positive cells that were enriched from peripheral blood
(Ma¨ndle et al., 2005), by the addition of interleukin-3
(IL-3), granulocyte-macrophage-colony-stimulating factor
(GM-CSF), and erythropoietin (epo) (Ma¨ndle et al.,
2005). However, as B. henselae infection did not affect
the differentiation of human HSCs into erythroid cells as
judged by CD34 and glycophorin A cell surface markers,
the results appear inconclusive given also the fact that
B. henselae readily invade HSCs (Ma¨ndle et al., 2005). It
is also well documented, as an example in the intravenous
B. tribocorum-rat reservoir host infection model, that after
injection the bacteria are rapidly cleared from circulating
blood within hours and that no bacteria can be detected
in the blood for about 4 days until the bacteremia peaks
(Schu¨lein et al., 2001). Also, the lag of several days post-
inoculation until the bacteria are sharply detected in the
blood with high numbers in the intradermal reservoir
host models (Chomel et al., 1996; Abbott et al., 1997;
Zhang et al., 2004; Marignac et al., 2010) does not sup-
port a circulatory nature of the primary niche.
Proposal of DCs and the draining lymph nodes
Upon exposure to microbial pathogens in peripheral tis-
sues such as the inflamed skin, DCs migrate to lymph
nodes and undergo maturation into potent immunostim-
ulatory cells, especially to evoke a clonal expansion of
antibody-producing B cells (Martı´n-Fontecha et al.,
2009). We have already described the current knowledge
of Bartonella spp.–DC interaction in ‘Means to affect
effector functions of professional phagocytes’. In short,
Bartonella spp. or at least B. grahamii in its natural reser-
voir host mouse is not able to circumvent DC recogni-
tion and activation, which appears of central importance
for several pathogenic bacteria such as Brucella spp. to
cause chronic infections (Billard et al., 2007). Actually,
B. grahamii seems to overactivate cytokine responses of
DCs, especially IFN-a/b secretion (Billard et al., 2007).
Bartonella grahamii infection causes a more severe regio-
nal lymphadenopathy in IFNAR1 (IFN-a/b receptor)-
deficient mice compared with the wild-type mice (Kunz
et al., 2008). This indicates that IFN-a/b overproduction
is limiting the B-cell recruitment and/or B-cell prolifera-
tion in the lymph nodes, the main cause of lymph node
swelling/lymphadenopathy. The final outcome is the
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inhibition of the antibody response and overall attenuation
of host immune surveillance, which in the end allows the
establishment of the chronic intraerythrocytic bacteremia.
We would like to propose here that the draining lymph
nodes are crucial anatomical sites first of all for the sup-
pression of B-cell responses and thereby antibody pro-
duction and secondly act as the anatomical site of the
primary niche in reservoir hosts. The latter argument
assumes that Bartonella spp. enter the draining lymph
node within DCs that are migrating from the site of
intradermal inoculation, although Bartonella spp. could
also hypothetically gain access to the lumen of lymphatic
vessels and eventually lymph nodes as a single bacterium
and/or bacterial auto-aggregates, which are known to be
formed by BadA of B. henselae (Kaiser et al., 2008) and
Vomps of B. quintana (Zhang et al., 2004). Viability of
the readily internalized Bartonella spp. in DCs (Vermi
et al., 2006) has not been reported, but it could be sig-
nificant based on the intracellular survival studies in
macrophages, which inherently have more potent bacteri-
cidal effects than DCs. Our proposal, like any other
current hypothesis, cannot yet answer the peculiar peri-
odicity of the bacterial appearance into the blood. Could
it be envisioned that the bacterial replication to a certain
density inside the lymph node–homed DCs would cause
synchronous lysis of the infected DCs? One potential
cytolytic bacterial factor is CAMP-like factor autotrans-
porter Cfa, which was identified in B. henselae to induce
hemolysis together with sphingomyelinase (Litwin &
Johnson, 2005). The activity of this protein toward
nucleated mammalian cells has not been reported, and it
could also be functional in the arthropod host. Strong
cytolytic activity of B. henselae has been identified toward
tick Amblyomma americanum cell line (Billeter et al.,
2009). There also appears to be a contact-dependent
hemolytic activity in B. bacilliformis, which is protease
sensitive, suggesting that it corresponds to a surface-
exposed protein (Hendrix, 2000). It remains to be stud-
ied whether this hemolysin is only present in B. bacilli-
formis and how important this potential hemolytic
activity actually is in the presence of the extremely potent
hemophagocytic activity of monocyte/macrophages
(Silva-Herzog & Detweiler, 2008). The lymph node pri-
mary niche hypothesis could also explain the rapid clear-
ance of bacteria from the circulating blood within hours
postinoculation, with bacteremia peaking only after few
days in the reservoir host intravenous infection models
(Koesling et al., 2001; Schu¨lein et al., 2001). It is difficult
to envision that bacteria could be migrating from the
blood-filtering lymph nodes into a more peripheral tissue
localization of the primary niche and then come back
few days later. In part, the lymph node primary niche
hypothesis is supported by the CSD in humans that is,
B. henselae infection in the incidental human host. Usu-
ally, 2–3 weeks after a bite or a scratch of an infected
cat, unusual lymphadenopathy of the lymph node(s)
draining the area of the scratch or the bite develops, may
suppurate and last for weeks (Klotz et al., 2011).
Bacterial factors involved in the colonization of
the primary niche
Several bacterial pathogens use type IV secretion systems
(T4SSs) to translocate bacterial effector molecules (pro-
teins or DNA) into the target host cells. These versatile
transporters have evolved from bacterial conjugation sys-
tems (Seubert et al., 2003; Christie et al., 2005). The
prototypic T4SS is the VirB/VirD4 apparatus of Agrobac-
terium tumefaciens, which mediates the transfer of the
tumorigenic T-DNA complex into the infected plant cells.
Mammalian pathogens have adapted T4SSs for the trans-
fer of proteins directly into the host cell cytosol (for
example, the CagA protein of Helicobacter pylori is trans-
ported into gastric epithelial cells) or for the export of
multisubunit protein toxins to the extracellular medium
(for example, pertussis toxin secreted by Bordetella pertus-
sis) (Christie et al., 2005), although they may still be
capable of translocating DNA (Schro¨der et al., 2011).
Bartonella spp. encode three distinct T4SSs, VirB/VirD4,
Vbh, and Trw, which appear as key pathogenicity factors
in mediating Bartonella spp.–host cell interactions (Schu-
lein & Dehio, 2002; Seubert et al., 2003; Schmid et al.,
2004; Vayssier-Taussat et al., 2010; Engel et al., 2011).
The Trw–T4SS will be discussed in detail in ‘Adhesion to
the erythrocytes’ and ‘Antigenic and phase variation of
surface proteins’ in the context of erythrocyte adhesion
and antigenic variation, respectively. The VirB/VirD4
T4SS has mainly been studied in B. henselae and
B. tribocorum, but it appears to be well conserved also in
other members of Bartonella spp., although it is absent in
B. bacilliformis (Sweger et al., 2000; Alsmark et al., 2004;
Saenz et al., 2007; Engel & Dehio, 2009; Engel et al.,
2011). Bartonella spp. species of the clade 2 (Fig. 1),
which apparently lack the VirB/VirD4-T4SS, contain a
distinct T4SS that is homologous to VirB/VirD4-T4SS
and is therefore designated as the virB-homolog-T4SS
(Vbh-T4SS) (Saenz et al., 2007). The Vbh-T4SS is absent
in B. bacilliformis and several species of the clade 4 (Saenz
et al., 2007). Cellular functions of the Vbh-T4SS have not
yet been studied in great detail (Engel et al., 2011).
The VirB/VirD4-T4SS of B. henselae is encoded by an
operon composed of 10 genes (virB2–virB11) and a
downstream-located virD4 gene (Schulein & Dehio, 2002;
Schulein et al., 2005) (Fig. 5). Its closest bacterial relative
is a genuine conjugation system, the AvhB/TraG system
of the pATC58 of A. tumefaciens (Schulein & Dehio,
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2002). A yeast two-hybrid interaction study of the com-
ponents of the B. henselae VirB/VirD4-T4SS has largely
confirmed the protein interactions that were previously
identified in other T4SSs (Shamaei-Tousi et al., 2004;
Christie et al., 2005) (Fig. 5). In analogy to the model
developed for the topology and function of these related
T4SSs (Christie et al., 2005), the B. henselae VirB/VirD4-
T4SS is considered to encompass a VirB2 pilin and VirB5
minor pilus components, which together form a pilus
that apparently can mediate contact with the host cell;
core components VirB3, VirB4, and VirB6–VirB11, which
form a pore complex that spans both Gram-negative
membranes; and the T4SS coupling protein VirD4, an
inner membrane protein believed to function as an
Fig. 5. Molecular characteristics of the VirB/VirD4-T4SS of Bartonella henselae. (a) A hypothetical model of the topology of B. henselae VirB/
VirD-T4SS based on studies on the archaetypical VirB/VirD4 T-DNA transfer system of plant pathogen Agrobacterium tumefaciens and yeast two-
hybrid screen of protein–protein interactions between VirB proteins of B. henselae (Shamaei-Tousi et al., 2004; Christie et al., 2005). VirB6 of
B. henselae has not yet been shown to interact with other VirB proteins. The coupling protein VirD4 is believed to recognize and target the
effectors for translocation via the core T4SS machinery composed of VirB2-VirB11. CY, bacterial cytosol; IM, bacterial inner membrane; PP,
bacterial periplasm; OM, bacterial outer membrane; EX, extracellular space. (b) Genetic organization of the genomic VirB/VirD4-T4SS locus. (c)
Modular domain organization of Beps. The filamentous induced by cAMP (FIC) domain is characterized by a short amino acid motif (HPFXXGNG)
of the catalytic center, which is highly conserved in Fic family proteins found in all domains of life and in viruses. Members of the Fic family of
adenylyltransferases catalyze covalent addition of AMP moieties to target proteins, either at threonine or at tyrosine residues. The enzymatic
activity was recently identified as the molecular basis how some pathogenic bacteria cause cytotoxicity through the modification of the switch I
regions of Rho GTPases (Worby et al., 2009; Yarbrough et al., 2009; Palanivelu et al., 2011), the key regulators of cellular actin dynamics. The
cellular functions of Bartonella spp. Fic proteins remain elusive. The BID domain and the adjacent positively charged C-tail are necessary for any
given Bep to be translocated via the VirB/VirD4-T4SS (Schulein et al., 2005). Some of the Beps carry in their N-terminus short peptide motifs
marked in black bars that resemble eukaryotic tyrosine phosphorylation motifs (e.g. EPLYA) (Selbach et al., 2009).
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interface between the pore complex and the T4SS protein
substrates (Fig. 5).
The proposed tip adhesin VirB5 (Fig. 5) is expressed
in vivo as an immunodominant protein of B. henselae, as
shown both after experimental infection of mice with
B. henselae (Padmalayam et al., 2000) and by analyzing the
sera of patients with CSD (Anderson et al., 1995). The
homologous T4SS in B. tribocorum is indispensable for the
establishment of the intraerythrocytic bacteremia in an
intravenous natural rat reservoir host model as evidenced
by comparative analysis of parental and VirD4- or VirB4-
deficient mutant bacteria (Schulein & Dehio, 2002). Inter-
estingly, a high fraction (> 80%) of VirB4-deficient mutant
bacteria, which had been genetically complemented by the
introduction of a virB4 copy in a replicative plasmid, were
recovered from the blood without the complementation
plasmid (Schulein & Dehio, 2002). The authors conclude
that this finding indicates the functional importance of
VirB/VirD4-T4SS for the initial abacteremic period of
approximately 1 week during which the bacteria reside,
replicate, and persist in the primary niche (Schu¨lein et al.,
2001; Schulein & Dehio, 2002). Indeed, it has recently been
reported that VirD4-deficient mutant of B. birtlesii is abac-
teremic in an intradermal natural mouse reservoir host
model, although the bacteria display equal erythrocyte
adherence and invasion rates in vitro as compared to the
parental strain (Vayssier-Taussat et al., 2010). At the
moment, it remains unknown which of the VirB/VirD4-
T4SS Bartonella spp. effector proteins, Beps (Fig. 5), are
involved and how they are involved in the invasion and
colonization of the primary niche and/or seeding of the
bacteria from the primary niche into the bloodstream.
However, BepD-deficient mutant has been identified in a
signature-tagged mutagenesis (STM) screen as abacteremic
(Saenz et al., 2007). This effector becomes tyrosine-phos-
phorylated by the host cell–derived tyrosine kinases (Schu-
lein et al., 2005) and therefore may interfere with the host
cell signaling processes. Tyrosine phosphorylation is a con-
served feature in several effectors translocated by bacterial
pathogens, as an example in the T4SS-effector CagA of
H. pylori (Odenbreit et al., 2000). Phosphorylation of CagA
by Src family and Abl kinases recruits SH2-domain con-
taining proteins such as tyrosine phosphatase Shp-2, tyro-
sine kinase Csk, and adaptor protein Crk, all having a
defined role in the H. pylori-induced cytoskeletal rear-
rangements (Odenbreit et al., 2000; Backert & Selbach,
2005). Recently, a nonbiased quantitative proteomics
approach was utilized to identify cellular target proteins
that bind to the tyrosine-phosphorylated peptides of BepD,
BepE, and BepF (Selbach et al., 2009). Several proteins
such as Grb2, Grb7, Csk, Crk, Shp1, and Shp2 were identi-
fied; however, the biology behind these interactions
remains to be studied.
BadA mediates bacterial binding to endothelial and
epithelial cells and extracellular matrix components
in vitro (Riess et al., 2004, 2007; Kaiser et al., 2008;
Mu¨ller et al., 2011). BadA-deficient mutants of B. triboco-
rum and B. birtlesii have been identified as abacteremic in
STM screens (Saenz et al., 2007; Vayssier-Taussat et al.,
2010). Strikingly, the BadA-deficient mutants isolated in
the B. birtlesii STM screen displayed equal erythrocyte
adherence and invasion rates in vitro as compared to the
parental strain (Vayssier-Taussat et al., 2010). This clearly
indicates that in analogy to VirB/VirD4-T4SS, BadA is
also required for the invasion and colonization of the pri-
mary niche and/or seeding of the bacteria from the pri-
mary niche into the bloodstream. Perhaps this also applies
to Vomps of B. quintana, because Vomp-deficient mutant
is abacteremic in an intradermal macaque model (MacKi-
chan et al., 2008). Several other bacterial factors with a pos-
sible role in the primary niche colonization, such as
inducible Bartonella autotransporter (iba) and several ABC
transporters, have been identified in the STM screens (Sae-
nz et al., 2007; Vayssier-Taussat et al., 2010). However,
their detailed molecular functions remain to be studied.
Adhesion to the erythrocytes
The hallmark of chronic Bartonella spp. infection in their
reservoir hosts, but not in the incidental hosts, is a long-
lasting intraerythrocytic bacteremia. This also applies to
the human-specific B. quintana (Rolain et al., 2002;
Rolain et al., 2003c), a louse-transmitted bacterium that
was initially detected during World War I as the causative
agent of trench fever (5-day fever), and B. bacilliformis
(Walker & Winkler, 1981; Benson et al., 1986), a sand
fly-transmitted bacterium (Maguin˜a et al., 2009). Barto-
nella bacilliformis is so far the only known species of
Bartonella spp. that cause deleterious effects for the
infected erythrocytes (Maguin˜a et al., 2009).
Bacterial adhesion is the first step in the erythrocyte
invasion process. Bartonella bacilliformis is highly motile
owing to the expression of multiple unipolar flagella
(Benson et al., 1986; Scherer et al., 1993), and it has been
reported that antibodies raised against the flagellin sub-
unit partially inhibit erythrocyte binding and almost com-
pletely abolish invasion (Scherer et al., 1993). However,
the direct role of flagella in erythrocyte adhesin per se
remains elusive by the lack of knowledge of the erythro-
cyte ligand and genetic proof, that is, parallel analysis of
wild-type and isogenic flagella-deficient mutant, although
this mutant exists (Battisti & Minnick, 1999). The fla-
gella-mediated motility could simply enhance bacteria–
erythrocyte collisions, and other surface protein(s) might
mediate the actual adhesion to the erythrocytes. This is in
part supported by the fact that most Bartonella spp. are
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nonflagellated but still capable of invading the erythro-
cytes. In a whole bacterium level, B. bacilliformis appears
to interact with multiple surface-exposed membrane pro-
teins of human erythrocytes, such as glycophorins A and
B (Buckles & McGinnis Hill, 2000). In this study, the
authors did not address the bacterial adhesin(s), but they
observed complete abrogation of binding to some of the
identified proteins following the exposure of erythrocytes
to sodium metaperiodate oxidation (Buckles & McGinnis
Hill, 2000). This indicates that carbohydrate moieties are
involved in the interactions between B. bacilliformis and
the human erythrocyte.
Recently, in vitro adhesion and invasion assays with
isolated erythrocytes that reproduce the host specificity of
erythrocyte infection as observed in vivo have been
reported for mouse-specific B. birtlesii, human-specific
B. quintana, cat-specific B. henselae, and rat-specific
B. tribocorum (Vayssier-Taussat et al., 2010). Moreover,
STM in the intravenous B. birtlesii-mouse infection
model allowed the identification of mutants that were
impaired in their ability to establish intraerythrocytic bac-
teremia. Among 45 abacteremic mutants, five failed to
adhere to and invade mouse erythrocytes in vitro. The
corresponding genes encode components of the type IV
secretion system (T4SS) Trw (Seubert et al., 2003), dem-
onstrating that this virulence factor is involved in the
adherence of B. birtlesii to the erythrocytes. Moreover,
ectopic expression of the Trw–T4SS of rat-specific
B. tribocorum in cat-specific B. henselae or human-specific
B. quintana expanded their host range for erythrocyte
infection to rat, demonstrating that Trw mediates host-
specific erythrocyte infection (Vayssier-Taussat et al.,
2010). Trw–T4SS had initially been identified in a differ-
ential fluorescence induction (DFI) screen as a B. henselae
promoter that is significantly upregulated during the
infection of ECs (Seubert et al., 2003). In the B. triboco-
rum-rat model, mutant deleted for the virB10-like trwE
gene was deficient in establishing the long-lasting intra-
erythrocytic bacteremia (Seubert et al., 2003). Trw–T4SS
and particularly its proposed pilus proteins TrwL and
TrwJ could be significant adhesins for Bartonella spp.
toward erythrocytes, because most of the species of Barto-
nella spp. have a genomic copy of Trw–T4SS (Engel &
Dehio, 2009). Interestingly, B. bacilliformis and other flag-
ellated bacteria appear to lack the Trw–T4SS, which
might indicate functional redundancy of Trw–T4SS and
flagella in erythrocyte adhesion and/or invasion (Dehio,
2008).
Invasion of the erythrocytes
The process of erythrocyte invasion by Bartonella spp.
appears to be fundamentally different from invasion of
nucleated cells, as mature erythrocytes do not contain an
active cytoskeleton that could be subverted by the bacte-
rium to assist in its uptake. Consequently, bacteria have
to enter erythrocytes by a process referred as forced endo-
cytosis (Benson et al., 1986) with most detailed knowl-
edge available for B. bacilliformis. One striking feature of
B. bacilliformis interaction with human erythrocytes is the
production of deeply invaginated pits and trenches in the
erythrocyte membrane (Benson et al., 1986), which are
considered to be the entry portals for invading bacteria.
This phenomenon appears to be triggered by a secreted
bacterial factor termed deforming factor or deformin
(Mernaugh & Ihler, 1992; Derrick & Ihler, 2001). Origi-
nally reported to be a protein (Mernaugh & Ihler, 1992),
later work by the same group has indicated that deformin
is a small hydrophobic molecule with high affinity for
albumin (Derrick & Ihler, 2001). Deformin can be
extracted from albumin as a heat- and protease-resistant,
water-soluble molecule with a molecular weight of
~ 1.4 kDa (Derrick & Ihler, 2001). It has been reported
that deformation activity, which is similar to B. bacillifor-
mis deformin, is also present in B. henselae (Iwaki-Egawa
& Ihler, 1997).
The invasion-associated locus (ial), composed of ialA
and ialB, is another putative virulence determinant impli-
cated in the erythrocyte invasion by B. bacilliformis. The
locus was identified in a heterologous expression system
where the ial locus but not the individual ialA and ialB
genes conferred an invasive phenotype to E. coli toward
human erythrocytes (Mitchell & Minnick, 1995). The ialA
gene encodes a 21-kDa protein, which has been reported
to have a nucleoside polyphosphate hydrolase (MutT
motif family) activity (Cartwright et al., 1999; Conyers &
Bessman, 1999). MutT motif family enzymes are believed
to eliminate toxic nucleotide derivatives and to regulate
the levels of important signaling nucleotides and their
metabolites (Mildvan et al., 2005). It remains to be stud-
ied if and how this enzymatic activity of IalA relates to
the process of erythrocyte invasion. The ialB gene encodes
an 18-kDa protein, which is well conserved (~ 60%
amino acid similarity) with the 17-kDa Ail (adhesion and
invasion locus) protein of Yersinia enterocolitica, which
mediate epithelial cell binding and invasion (Leo & Skur-
nik, 2011). Indeed, the association of isogenic IalB-defi-
cient mutant of B. bacilliformis with human erythrocytes
is significantly reduced although not completely absent
(Coleman & Minnick, 2001). This indicates that other
bacterial factors are involved, possibly flagella (Benson
et al., 1986; Scherer et al., 1993). The regulation of IalB
expression by environmental cues has also been studied,
and most strikingly, the low pH appeared as a strong
stimulus for IalB expression and/or stability increase at
the protein level (Coleman & Minnick, 2003). At the
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moment, the functional implications of this observation
can only be speculated. Low pH–IalB association might
be significant outside the context of B. bacilliformis–eryth-
rocyte interaction, perhaps in the survival of bacteria
inside professional phagocytes. The IalB-mediated eryth-
rocyte invasion might be a significant pathogenic strategy
for Bartonella spp. in general because the ialAB locus is
conserved in many species (Engel & Dehio, 2009).
Indeed, STM in the intravenous B. tribocorum-rat infec-
tion model allowed the identification of 97 different pro-
tein-encoding genes that were important for the bacteria
to establish the intraerythrocytic bacteremia and two
independent insertional mutants mapped to the ialB gene
(Saenz et al., 2007). Moreover, intact ialAB locus was
shown to be essential for B. birtlesii to establish an intra-
erythrocytic bacteremia in a natural mouse reservoir host
infection (Vayssier-Taussat et al., 2010). The abacteremic
behavior of IalAB-deficient B. birtlesii correlated with
defective erythrocyte invasion in vitro, although the
adherence to the erythrocytes per se was not affected
(Vayssier-Taussat et al., 2010). The exact molecular
mechanism [e.g. the putative cell surface ligand(s)] by
which the IalAB contributes to the erythrocyte invasion
remains elusive.
The STM screens on B. birtlesii and B. tribocorum
allowed the identification of an IalAB-independent eryth-
rocyte invasion locus, the liv locus (Saenz et al., 2007;
Vayssier-Taussat et al., 2010). Bartonella birtlesii with an
inactivating insertion in the livG gene and B. tribocorum
with an inactivating insertion in the livF gene were iden-
tified. Moreover, the B. birtlesii livG mutant was shown
to have a drastically decreased capacity to invade erythro-
cytes in vitro, although the adhesion to the erythrocytes
per se was not significantly affected (Vayssier-Taussat
et al., 2010). In the B. tribocorum genomic sequence, the
livG and lifF genes have been annotated as ATPase com-
ponents of a putative amino acid ABC transporter (Saenz
et al., 2007). These genes are also highly conserved in
other members of Bartonella spp. It remains to be studied
how the products of the novel liv locus mediate their
apparent role in erythrocyte invasion. It is also possible
that Liv system is required for the uptake of amino acid
as nutrients for the invading bacteria inside the erythro-
cytes.
Metabolic adaptations to the host
Successful pathogen not only produces virulence factors
ideally for a subclinical infection but also metabolically
persists in the host with a minimal own input. A striking
example of Bartonella spp.. host-integrated metabolism is
represented by heme, a crucial cofactor in many enzy-
matic processes. Early work demonstrated that Brucella
broth with 6–8% of Fildes solution and 250 lg of hemin
per ml supported the in vitro growth of B. henselae up to
OD600 nm of 0.6 already on day 3 postinoculation as com-
pared to virtually nongrowing culture up to day 9 postin-
oculation without the hemin supplement (Schwartzman
et al., 1993). More recently, it was reported that the
in vitro growth-promoting effect of blood supplement for
B. henselae on Brucella agar could be reproduced by the
addition of hemin or hemoglobin (Sander et al., 2000a).
These findings indicate that growth of B. henselae is depen-
dent on exogenous heme-containing compounds. Indeed,
heme biosynthetic genes are largely missing in the genome
of B. henselae (Alsmark et al., 2004) and also in the
genomes of other Bartonella spp. such as B. quintana (Als-
mark et al., 2004) and B. tribocorum (Saenz et al., 2007).
As an example, gtrH gene encoding for the HemH ferroch-
elatase that is responsible for the insertion of ferrous iron
into protoporphyrin IX as the terminal step in proto-heme
biosynthesis (Panek & O’Brian, 2002) is lacking. This is in
accordance with the observation that addition of heme pre-
cursor protoporphyrin IX in combination with iron is not
sufficient to rescue the in vitro growth defect of B. henselae
on Brucella agar (Sander et al., 2000a).
Heme is particularly abundant in the host niches colo-
nized by Bartonella spp., that is, the erythrocytes and the
mid-gut lumen of blood-sucking arthropods. Otherwise
in the mammalian host, the free heme concentration is
low because of the action of heme-binding plasma pro-
teins (Baker et al., 2003). In fact, even in the case of
erythrocyte invasion in the blood of a reservoir host, vac-
uolar rupture inside the erythrocytes is expected for the
bacterium to gain access to high amounts of heme. At
the moment, no such activity is known except possibly
for B. bacilliformis (Hendrix, 2000) and B. henselae (Li-
twin & Johnson, 2005), and therefore, efficient scavenging
and uptake mechanisms are expected to be present in
Bartonella spp. Indeed, Bartonella spp. have high abun-
dance of genes encoding for proteins implicated in heme
uptake (Alsmark et al., 2004; Saenz et al., 2007; Engel &
Dehio, 2009). Experimentally, a surface-exposed hemin-
binding ~25-kDa protein, designated as HbpA (Carroll
et al., 2000), has been identified in B. quintana with
homologs present in B. bacilliformis, B. clarridgeiae,
Bartonella elizabethae, Bartonella doshiae, B. vinsonii
Berkhoffii, and B. henselae where the protein is also
known as the Pap31 (Bowers et al., 1998; Zimmermann
et al., 2003; Maggi & Breitschwerdt, 2005). In B. quin-
tana, four additional homologs, HbpB–HbpE, are present
indicating the physiological importance of exogenous
heme binding (Minnick et al., 2003b), although direct
evidence for bacterial surface localization is so far only
available for HbpA (Carroll et al., 2000) and HbpE
(Boonjakuakul et al., 2007). The five-member heme-
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acquisition gene family (hbpA–hbpE) has a peculiar regu-
lation pattern in B. quintana (Battisti et al., 2006, 2007).
At the level of mRNA, it has been shown that hbpC is sig-
nificantly over-represented at 30 °C (louse-like) relative
to 37 °C (human-like). High heme concentrations such
as 5.0 mM (louse-like), close to the concentrations that
become bactericidal, lead into significant over-representa-
tion of mRNA for hbpB and hbpC relative to 0.15 mM
heme. On the other hand, low heme concentrations such
as 0.05 mM (human-like), close to the concentrations
that become growth limiting, lead into significant over-
representation of mRNA for hbpA, hbpD, and hbpE rela-
tive to 0.15 mM heme (Battisti et al., 2006, 2007). The
authors propose that B. quintana utilize its HbpA–HbpE
repertoire in a very distinct manner, that is, HbpA,
HbpD, and HbpE are employed when heme is growth
limiting such as in the circulation of the reservoir host
human and HbpB and especially HbpC are employed
when B. quintana encounter extremely high and toxic
concentrations of heme such as in the mid-gut lumen of
its arthropod host body louse (Battisti et al., 2006). The
data imply that HbpA–HbpE proteins might have differ-
ential subcellular localization, perhaps even extracellular
and/or avidity to heme to fulfill their apparently diverse
and putative functions in heme acquisition and detoxifi-
cation. An additional heme utilization system has been
identified in B. quintana (Parrow et al., 2009). Genomic
analyses revealed a locus encoding for a putative heme
receptor (HutA), a TonB-like energy transducer (an ABC
transport system comprised three proteins HutB, HutC,
and HmuV), and a hemin degradation/storage enzyme,
HemS (Andrews et al., 2003; Alsmark et al., 2004; Parrow
et al., 2009). Direct functional evidence was provided for
HutA heme receptor in a heterologous complementation
analysis in E. coli (Parrow et al., 2009). The importance
of heme acquisition/detoxification for Bartonella spp. has
also been observed in a natural reservoir host infection
model. STM in the intravenous B. bacilliformis-rat infec-
tion model allowed the identification of 97 different pro-
tein-encoding genes that were important for the bacteria
to establish the intraerythrocytic bacteremia, and 10 inser-
tions were mapped to genes with putative functions in
heme uptake such as hbpB and hutA (Saenz et al., 2007).
HutA was also identified as an essential protein in an
STM screen for factors that are important for B. birtlesii
to establish an intraerythrocytic bacteremia in a natural
reservoir host mouse (Vayssier-Taussat et al., 2010).
In conclusion, it appears that acquisition/detoxification
of exogenous heme is of crucial importance for the
metabolism of B. henselae, B. quintana, and B. tribocorum
and most likely this applies to most, if not all, species of
Bartonella spp.. In addition of being a crucial metabolite,
heme might also elicit profound homeostatic functions
for Bartonella spp. as proposed by Battisti et al. (2006).
Bartonella spp. lack peroxidases and heme-cofactored cat-
alase but strikingly also Dps/Dpr proteins, which are
indispensable for oxygen and H2O2 resistance of one
other significant catalase-negative group of bacteria, strep-
tococci (Yamamoto et al., 2000; Pulliainen et al., 2003,
2005). Bartonella spp. are members of the order Rhizobi-
ales, along with some other important human (Brucella
spp.) and plant (Agrobacterium spp.) pathogens. Many
rhizobia form a symbiotic relationship with their host
plant by fixing atmospheric nitrogen in root nodules. For
nitrogen fixation to occur, a microaerophilic environment
must be established for the bacteria. This is accomplished
by the plant-generated leghemoglobin (a molecule similar
to hemoglobin) binding to the rhizobial surface, effec-
tively shielding the bacteria, and oxygen-labile nitroge-
nase, from oxygen (Ott et al., 2005). Due to the fact that
Bartonella spp. possess multiple surface-associated heme-
binding proteins (Alsmark et al., 2004; Battisti et al.,
2006; Saenz et al., 2007; Parrow et al., 2009), it has been
speculated that heme binding could be a significant strat-
egy to shield B. quintana from oxygen and thereby also
from the partially reduced forms of oxygen; superoxide
(O2 ), hydrogen peroxide (H2O2), and hydroxyl radical
(˙OH) (Battisti et al., 2006). This interesting hypothesis
of an evolutionary conserved strategy used by members
of Rhizobiales to decrease oxygen in their environments
remains to be studied.
One peculiar metabolic feature of Bartonella spp. is
their apparent inability to use glucose as the primary car-
bon source, although glucose should be abundant in the
host tissues and blood. When B. henselae was first iso-
lated from the blood of patients infected with human
immunodeficiency virus (HIV), preliminary characteriza-
tion did not detect carbohydrate utilization (Regnery
et al., 1992; Welch et al., 1992). In a similar fashion,
B. quintana do not appear to metabolize glucose (Huang,
1967; Weiss et al., 1978). More recently, it was observed
in part of a study aimed to develop a robust liquid
growth media for Bartonella spp. that B. henselae do not
consume glucose (Chenoweth et al., 2004). In contrast,
B. henselae depleted amino acids and accumulated ammo-
nia into the culture medium, an indicator of amino acid
catabolism. Carbon dioxide was produced indicating that
the amino acids were catabolized in a tricarboxylic acid
cycle–dependent manner (Chenoweth et al., 2004). What
are the physiological implications of the amino acid–
dependent catabolism in Bartonella spp.? At the moment,
it can only be speculated that this type of metabolism
might have evolved together with the host heme utiliza-
tion. It is expected that proteins are actually more abun-
dant than glucose in the host niches colonized by
Bartonella spp., that is, the erythrocytes after heme
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sequestration from hemoglobin by the bacteria and espe-
cially the mid-gut lumen of blood-sucking arthropods
after digestive enzymes of the arthropod have processed
the ingested erythrocytes.
Evasion of host adaptive immune response
Antigenic and phase variation of surface proteins
Intracellular localization of Bartonella spp. in reservoir
host erythrocytes is undoubtedly one of the most effi-
cient means to subvert both the humoral and the cellular
immune responses. Owing to the lack of major histo-
compatibility molecules on their surfaces, erythrocytes
are unable to present antigens of their invaders to the
immune system. However, the host is eventually able to
clear the infection by antibodies within the limits of nat-
ural life span of the erythrocytes (Fig. 2), at least based
on studies in the natural B. grahamii mouse infection
model (Koesling et al., 2001). This is probably due to
the opsonization of the bacteria that are periodically
seeded from the primary niche into the bloodstream
and thereby inhibition of the bacterial binding to the
erythrocytes.
When the reservoir host produces antibodies targeted
against the invading Bartonella spp., the strong selective
pressure is expected to favor the appearance of clonal
populations where the pathogen has altered the expressed
surface-exposed antigens (antigenic variation), or no
longer express the antigen on its surface because of phase
variation or partial or total gene loss (Bayliss, 2009). The
total gene loss has been directly witnessed in vivo in
B. quintana-macaque reservoir host infection model
(Fig. 6) (Zhang et al., 2004). A clone was isolated from
the blood 70 days after an intradermal inoculation, and it
was shown that the genes encoding for two of its initial
four surface-exposed TAAs, the Vomp adhesins, had been
deleted (Zhang et al., 2004). Vomps are important pro-
teins for B. quintana to establish intraerythrocytic bacter-
emia after an intradermal inoculation in the macaque
model (MacKichan et al., 2008) and in vitro mediate bac-
terial adhesion to ECs (Mu¨ller et al., 2011) and binding
to ECM components such as collagen (Zhang et al., 2004;
Mu¨ller et al., 2011). Moreover, nine independent human
primary isolates of B. quintana were shown to have six
different restriction fragment length polymorphism pat-
terns as judged by Southern blotting with a probe anneal-
ing to a conserved 5′-region of VompA, VompB, and
VompC (Zhang et al., 2004). The data indicate that
Vomp locus may be a subject to extensive genetic rear-
rangements in vivo including changes in the copy number
of the genes. Strong selective pressure for alterations in
Vomp expression and surface display is highlighted by
observation that Vomp-specific antibodies are the most
frequently detected anti-B. quintana antibodies in the
sera of human patients infected with B. quintana
(Boonjakuakul et al., 2007). The emergence of genetically
distinct clones at various peaks of relapsing bacteremia
has also been witnessed in a natural B. henselae-cat reser-
voir host infection model (Kabeya et al., 2002).
BadA of B. henselae, which resembles Vomps, is vari-
ably surface-exposed in different strains resulting in some
cases to complete lack of EC adhesion (Riess et al., 2007).
It remains to be shown whether BadA is subject of phase
variation in vivo. At the moment, it is believed that the
detected loss of surface localization in some strains in
vitro is because of the loss of costly expression of the
large ~ 300-kDa BadA upon extensive passaging of strains
on blood agar plates (Kempf et al., 2001; Riess et al.,
2007). BadA has a modular domain structure, that is, an
N-terminal head region, a long and highly repetitive stalk
and neck region, and a C-terminal membrane anchor
domain (Riess et al., 2004, 2007; Kaiser et al., 2008)
(Fig. 6). It has been proposed that the repetitive tandem
DNA sequences encoding for the stalk domains of BadA
increase the frequency of recombination and thereby the
generation of variable surface-displayed adhesins with a
net outcome of antigenic variation (Linke et al., 2006).
Indeed, it has been observed that of the nine analyzed
B. henselae strains virtually, every strain had its own stalk
length, whereas the length of the head and the membrane
domains were constant (Riess et al., 2007).
Extremely potent source of antigenic variability is dis-
played by Trw–T4SS, which is a crucial molecular deter-
minant of erythrocyte adhesion and appears as an
important mediator of reservoir host specificity (Seubert
et al., 2003; Vayssier-Taussat et al., 2010) (Fig. 6). Trw–
T4SS was initially identified in a DFI screen as a B. hense-
lae promoter that is significantly upregulated during the
infection of ECs (Seubert et al., 2003). In the B. triboco-
rum-rat model, mutant deleted for the virB10-like trwE
gene is deficient in establishing the long-lasting intra-
erythrocytic bacteremia (Seubert et al., 2003). The most
striking feature of Trw–T4SS is the remarkable locus
expansion by tandem gene duplications (Fig. 6). In addi-
tion, the different copies of the major pilus components
TrwL (seven tandem repeats of trwL) and of the minor
pilus component TrwJ (five tandem repeats of the trwJIH
region) display a large degree of sequence variation. In
contrast, the different copies of the lipoprotein TrwH,
which is considered to link the pilus to the core complex
(Krall et al., 2002), and the inner membrane protein
TrwI, known to be essential for the stabilization of TrwJ
(Krall et al., 2002), are basically identical. The tandem
gene duplications of Trw–T4SS components are not
restricted to B. tribocorum because both B. henselae
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Houston-1 and B. quintana Toulouse harbor two copies
of trwJ and eight copies of trwL (Alsmark et al., 2004).
The striking difference in sequence conservation between
paralogues of the co-amplified trwJIH genes in B. triboco-
rum suggests that, after gene duplication, these genes have
been exposed to differential selection pressure (Seubert
Fig. 6. Major adhesins of Bartonella spp. (a) Schematic representation of BadA of Bartonella henselae and variably expressed OMPs (Vomps) of
Bartonella quintana and comparison to Yersinia adhesin A (YadA) of Yersinia enterocolitica. These TAAs are composed of an N-terminal signal
peptide (black bar), the head sequence, variable neck and stalk repeats, and the C-terminal membrane anchor. It has been observed that virtually
every B. henselae strain has its own neck/stalk length, whereas the length of the head and the membrane anchor domains are constant (Riess
et al., 2007). (b) Surface expression of BadA and Vomps detected by transmission electron microscopy (Mu¨ller et al., 2011). Note the expression
of long proteinaceous surface appendices (length, ~ 250 nm) on the surface of B. henselae wild-type (missing in the B. henselae BadA-deficient
strain) and on the surface (length, ~ 40 nm) of B. quintana JK31 (missing in B. quintana BQ2-D70). Note the electron-dense globular structure
on the top of the BadA and Vomps (marked by an arrow), presumably representing the head domain (scale bar 300 nm). (c) Schematic
representation of the Vomp locus of B. quintana JK-31. As an indication of high antigenicity of Vomps and their possible temporal role in
pathogenesis, total gene loss has been witnessed in vivo in a natural B. quintana-macaque reservoir host infection model. A clone (BQ2-D70) was
isolated from the blood 70 days after an intradermal inoculation, and it was shown that the genes encoding for two of its initial four surface-
exposed Vomp adhesins had been deleted (Zhang et al., 2004). (d) Trw–T4SS mediates erythrocyte adhesion (Vayssier-Taussat et al., 2010).
Genetic organization of the chromosomal trw locus encoding for the Trw–T4SS of Bartonella tribocorum (Seubert et al., 2003). The most striking
feature of Trw–T4SS, also in other species (Nystedt et al., 2008), is the partial locus expansion by gene multiplications. In addition, the different
copies of the major pilus components TrwL and of the minor pilus component TrwJ display a large degree of sequence variation. Details are
described in the text (see Antigenic and phase variation of surface proteins).
ª 2012 Federation of European Microbiological Societies FEMS Microbiol Rev 36 (2012) 563–599
Published by Blackwell Publishing Ltd. All rights reserved
582 A.T. Pulliainen & C. Dehio
et al., 2003; Nystedt et al., 2008). Diversifying selection
for mutations in trwJ and/or trwL would generate variable
pilus forms, which may allow the interaction with differ-
ent host cell surface structures (e.g. different ligands on
the erythrocyte surface) and eventually even lead into
host switch or may represent a general mechanism of
immune evasion by antigenic variation. In contrast, nega-
tive selection against the accumulation of mutations in
trwI or trwH paralogues may result from a deleterious
dominant-negative effect of those mutations on the integ-
rity and function of the Trw–T4SS, as has been described
for homologous systems (Dang et al., 1999; Sagulenko
et al., 2001). Currently, it remains unknown whether pool
of all the possible TrwJ, TrwL, TrwI, and TrwH proteins
is expressed. Potentially, there could be a mechanism that
allows selective isoform-specific expression and/or display.
In conclusion, antigenic and phase variation appears as a
common persistence strategy for Bartonella spp., at least
based on the current in vitro and in vivo knowledge of
Trw–T4SS, BadA, and Vomps. Several nonbiased screen-
ing studies have been conducted to identify immunogenic
surface-exposed proteins in Bartonella spp. (Minnick,
1994; Rhomberg et al., 2004; Boonjakuakul et al., 2007;
Eberhardt et al., 2009) mainly for serodiagnostic pur-
poses, but this information might become useful in the
future to also understand how Bartonella spp. evade
adaptive immunity and persist in the mammalian host.
Molecular basis of Bartonella spp.-
triggered vascular tumorigenesis in
human
Introduction to the Bartonella spp.-triggered
vascular tumorigenesis
The role of viruses such as hepatitis B virus or human pap-
illoma virus in carcinogenesis is widely accepted because of
direct mechanistic effects of single viral gene products in
cell transformation. Some bacteria, such as H. pylori, are
also associated with malignant cell transformation (Lax &
Thomas, 2002). Bartonella spp. and in particular B. bacilli-
formis, B. quintana, and B. henselae are unique in the bac-
terial kingdom in causing vasoproliferative tumor
formation (Fig. 7). Human infection by B. bacilliformis can
be divided into two distinct clinical phases. The initial
acute phase of the disease (Oroya fever) is characterized by
hemolytic anemia. The second phase occurs after clinical
recovery from the acute phase and is characterized by the
eruption of crops of nodular tumor-like skin lesions or fer-
ruginous skin lesions, or both, predominantly on the head
and distal extremities (Maguin˜a et al., 2009). The partial
state of immunosuppression that evidently develops at the
end of the Oroya fever is considered to favor the formation
of vasoproliferative lesions (verruga peruana) (Dehio,
2005). Immunosuppression is also a prerequisite for vascu-
lar tumor formation by B. henselae and B. quintana (Ma-
guin˜a et al., 2009). BA caused by both of these species is
characterized by vasoproliferative skin lesions, which
resemble Kaposi’s sarcoma caused by human herpes virus 8
infection in patients with AIDS (Tappero & Koehler, 1997;
Relman et al., 1999). BA was described in 1983 (Stoler
et al., 1983), and it has occurred most commonly in
patients with severe immunosuppression caused by the
HIV. BA has also occurred in immunocompetent individu-
als. However, in these cases, the patients have apparently
experienced transient immunosuppression owing to organ
transplantation or chemotherapy (Cockerell et al., 1990;
Myers et al., 1992; Tappero et al., 1993). Bartonella hense-
lae can also trigger the formation of vasoproliferative
lesions in inner organs such as in liver and spleen, a clinical
state known as the BP (Welch et al., 1992). Histologically,
BA and BP lesions are composed of individual bacteria or
clusters of bacteria, proliferated, and misshapen ECs, which
may form capillary-like sprouts, and a mixed infiltrate of
leukocytes such as monocyte/macrophages and PMNs
(Kostianovsky & Greco, 1994). Bartonella spp.-triggered
vascular tumorigenesis has been mainly studied in vitro
using monolayers of primary human umbilical-vein ECs
(HUVECs) with the most detailed knowledge available for
B. henselae. Some studies have also been conducted with
HUVECs or HUVEC spheroids that have been embedded
in a three-dimensional matrix such as a collagen gel or Ma-
trigel (Kirby, 2004; McCord et al., 2006; Scheidegger et al.,
2009; Berrich et al., 2011; Scheidegger et al., 2011). Devel-
opment of an animal model of BA/BP would be essential to
define the molecular basis of Bartonella spp.-triggered vas-
cular tumorigenesis.
Endothelial cell adhesion and subsequent
invasion
Colonization of vascular endothelium and persistence
therein is generally accepted as a crucial step in the estab-
lishment and maintenance of Bartonella spp.-triggered
vascular deformations. Each of the three vasoprolifera-
tion-inducing Bartonella spp. species adheres to and
invades ECs in vitro (Hill et al., 1992; Brouqui & Raoult,
1996; Dehio et al., 1997). The vascular pathologies could
reflect a general tropism of Bartonella spp. for the vascu-
lar endothelium, that is, the ECs could be the still-
enigmatic primary niche (see Identity of the primary niche).
Bartonella quintana and B. bacilliformis
In molecular terms, B. quintana–EC interaction is poorly
understood. However, it appears that the bacterium is
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able to adhere to and invade ECs in vitro (Brouqui &
Raoult, 1996; Palmari et al., 1996; Mu¨ller et al., 2011).
Actin rearrangements have been reported (Palmari et al.,
1996), which may be necessary for the bacterial uptake.
Recently, it was shown that the large and variably
expressed Vomp adhesins are important to mediate the
adhesion of B. quintana to HUVECs (Mu¨ller et al., 2011).
In the case of B. bacilliformis, the invasion of ECs appears
to require actin remodeling because cytochalasin D, a
cell-permeable inhibitor of actin polymerization, inhibits
bacterial uptake (Hill et al., 1992). Based on an electron
microscopy study, the bacteria invaded the EC within
1 h, forming a small membrane-bound inclusion, the
BCV. By 12 h, a large membrane-bound inclusion, similar
to the cytoplasmic inclusions of verruga peruana patients’
ECs, containing numerous bacteria was present (Garcia
et al., 1992). Most likely, these inclusions represent bacte-
ria that have been multiplying within a single BCV or
a fusion vesicle of multiple BCVs. Pretreatment of the
ECs with Clostridium botulinum C3 transferase, which
inactivates one key regulator of actin reorganization,
Rho-GTPase, via ADP ribosylation, strongly inhibited the
bacterial internalization (Verma et al., 2000). This is in
accordance with the marked activation and plasma mem-
Fig. 7. Schematic representation of a model of Bartonella henselae-triggered vascular tumorigenesis. (a) Bartonella henselae displays marked
tropism toward vascular ECs, resulting in bacterial adherence and invasion. BadA mediates the adhesion of B. henselae to host cells, possibly via
a fibronectin bridge to integrins. BadA also mediates bacterial auto-aggregation (Riess et al., 2004). A cocktail of different Beps is translocated
from B. henselae via the VirB/VirD4-T4SS into the host cell (Pulliainen & Dehio, 2009). By their inherent or cell-modified properties, the effectors
are targeted into different subcellular compartments to mediate their diverse functions. Cytoskeletal rearrangements mediated by BepC, BepG,
and BepF result in the uptake of a large bacterial aggregate via the invasome structure, and this is believed to favor a long-term host cell
colonization (Rhomberg et al., 2009; Truttmann et al., 2011a, b, c). (b) A schematic representation of the molecular basis of BepA-mediated
subversion of host cell cAMP signaling. Translocation of BepA into ECs coincides with an elevation of cytosolic cAMP concentration (Schmid
et al., 2006). Recent data indicate that after the T4SS-mediated translocation, BepA directly binds host cell adenylyl cyclase to potentiate Gas-
dependent cAMP production (A.T. Pulliainen et al., submitted). As opposed to the known microbial mechanisms such as ADP ribosylation of
G-protein a-subunits by cholera and pertussis toxins, the fundamentally different BepA-mediated elevation of host cell cAMP concentration is
subtle and strictly dependent on the release of Gas from G-protein-coupled receptors by agonist stimulation. We propose that this mechanism is
ideal for the chronic and stealthy persistence of B. henselae in the vascular endothelium.
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brane localization of Rho upon B. bacilliformis infection
of ECs as judged by an affinity capture system to precipi-
tate the activated form of Rho (Rho-GTP) with Rho
effector protein, rhotekin (Verma et al., 2000). Moreover,
the other two major GTPases that are involved in actin
remodeling, Rac and Cdc42, became activated, and this
activation was associated with the formation of filopodia
and lamellipodia together with bacterial clumping on the
surface of the ECs (Verma & Ihler, 2002). In conclusion,
it appears that B. bacilliformis and most likely also
B. quintana actively subvert EC signaling to promote
their internalization by a process resembling classical bac-
terium-forced phagocytic entry into normally nonphago-
cytic cells (Cossart & Sansonetti, 2004).
Bartonella henselae
Early work indicated that B. henselae infection induces
morphological changes in human ECs. The infected cells
became larger, more elongated, spindle shaped and dis-
played actin rearrangements (Palmari et al., 1996). In
1997, it was shown that B. henselae actually enters HU-
VECs by two distinct routes (Dehio et al., 1997). Barto-
nella henselae may first of all enter the cell as individual
bacteria through a classical forced phagocytic pathway,
which resemble the BCV-uptake mechanisms of B. bacilli-
formis (Garcia et al., 1992). Alternatively, B. henselae may
enter the cell as large bacterial aggregates that are formed
on the cell surface, followed by their engulfment and
internalization via the invasome structure in an actin-
dependent manner. Typical appearance of the invasome is
a solitary, globular structure of 5–15 lm in diameter,
which may contain several hundreds of bacteria. The
invasome-mediated cell entry has slower kinetics (days)
when compared to the BCV-mediated uptake (hours)
(Dehio et al., 1997). The in vivo relevance of the inva-
some-mediated uptake is unclear; however, the bacterial
aggregates that are formed in this process could corre-
spond to the clumps of bacteria that are observed in his-
tology sections of BA lesions (Tappero & Koehler, 1997;
Relman et al., 1999). Moreover, it appears that the inva-
somes do not acquire typical lysosomal markers such as
LAMP-1 in vitro (Rhomberg et al., 2009) within the same
timeframes when BCVs have fused with the lysosomes
(Kyme et al., 2005; Rhomberg et al., 2009). Invasome-
mediated uptake could therefore represent an invasion
strategy that is preferred over the BCV uptake and allows
B. henselae to establish a chronic infection of the vascula-
ture. In addition to the early work (Palmari et al., 1996;
Dehio et al., 1997), several investigators have reported
that B. henselae adheres to and efficiently invades primary
ECs and also immortalized endothelial cell hybridomas
such as Ea.hy926 (Kempf et al., 2000; Resto-Ruiz et al.,
2000; Fuhrmann et al., 2001; Kempf et al., 2001;
Schmiederer et al., 2001; Riess et al., 2004; Kyme et al.,
2005; Riess et al., 2007; Kaiser et al., 2008; Chang et al.,
2011; Mu¨ller et al., 2011).
Major adhesin of B. henselae toward ECs is BadA
(Riess et al., 2004), although the EC invasion apparently
takes place in vitro even in the absence of this TAA
(Dehio et al., 1997; Riess et al., 2007). There are indica-
tions that the BadA ligand on EC surface is b1-integrin
via a fibronectin bridge (Riess et al., 2004) (Fig. 7). The
possible BadA–fibronectin–integrin triad in B. henselae
cell entry would be analogous to the cell entry mechanism
of Gram-positive pathogen Staphylococcus aureus. This
bacterium recruits fibronectin to its surface, a process
that is mediated by a direct interaction between fibronec-
tin and the bacterial cell-wall-attached proteins FnBP-A
and FnBP-B (Jo¨nsson et al., 1991). The interaction of the
bacteria-bound fibronectin with its native receptor, inte-
grin a5b1, initiates integrin clustering and bacterial inter-
nalization into host cells (Agerer et al., 2003). The
importance of b1 integrin both as the cellular ligand and
an active signaling component in B. henselae-induced
invasome formation has recently been identified in a
HeLa cell-based RNA interference screen (Truttmann
et al., 2011a, b, c). Interestingly, these data were acquired
with a B. henselae strain (Houston-1) that apparently
lacks BadA expression. Accordingly, the Houston-1 strain
did not significantly bind fibronectin, but at the same
time it displayed a strong binding activity toward b1 inte-
grin. This indicates that B. henselae express direct adhe-
sins for b1 integrin. One possible candidate could be the
43-kDa OMP Omp43, which has been reported to bind
ECs (Burgess & Anderson, 1998; Burgess et al., 2000).
VirB/VirD4-T4SS
Expression of the B. henselae virB operon (Fig. 5) is
induced upon EC interaction (Schmiederer et al., 2001;
Quebatte et al., 2010). Moreover, it has been reported that
the VirB4-deficient B. henselae strain is incapable of
inducing its invasome-mediated uptake into HUVECs
(Schmid et al., 2004). Internalization of the mutant
through the BCV invasion appeared equal or even more
pronounced as compared to the parental strain (Schmid
et al., 2004). Recently, three of the total of seven currently
known VirB/VirD4-T4SS effector proteins (Schulein et al.,
2005; Pulliainen & Dehio, 2009), that is, Bartonella
effector proteins BepC, BepF, and BepG (Figs 5 and 7),
were shown to be involved in the invasome-mediated
bacterial uptake (Rhomberg et al., 2009; Truttmann et al.,
2011a, b, c). Interestingly, there appears to be functional
redundancy. First of all, expression of BepG in the
Bep-deficient (DbepA–G) mutant restores the invasome-
FEMS Microbiol Rev 36 (2012) 563–599 ª 2012 Federation of European Microbiological Societies
Published by Blackwell Publishing Ltd. All rights reserved
Mechanisms of Bartonella spp. stealth pathogen persistence 585
mediated uptake. Likewise, ectopic expression of BepG in
ECs also restores the invasome-mediated uptake of the
Bep-deficient (DbepA–G) mutant. Both of the above
effects appear to inhibit the BCV route of cell entry.
Indeed, ectopic expression of BepG in ECs also blocks het-
erologous endocytic processes such as the uptake of inert
microspheres (Rhomberg et al., 2009). The authors pro-
pose that BepG triggers the invasome-mediated bacterial
uptake primarily by inhibiting bacterial endocytosis into
BCVs. Bacteria accumulating at the cell surface, which
could be assisted by BadA-mediated auto-aggregation
(Riess et al., 2004; Kaiser et al., 2008) (Fig. 7), then
induce locally the F-actin rearrangements characteristic for
the invasome formation. These cytoskeletal changes
include both the rearrangements of pre-existing F-actin
fibers and the de novo polymerization of cortical F-actin
in the periphery of the invasome by Rac1/Scar1/WAVE-
and Cdc42/WASP-dependent pathways that involve the
recruitment of the Arp2/3 complex (Rhomberg et al.,
2009). Secondly, co-infections of HUVECs with the
Bep-deficient (DBepA–G) mutant expressing either BepC
or BepF restore invasome formation. Likewise, ectopic
co-expression of BepC and BepF enables invasome-
mediated uptake of the Bep-deficient (DBepA–G) mutant
strain. Furthermore, the combined action of BepC and
BepF inhibits the endocytic uptake of inert microspheres.
The invasome formation induced by the concerted action
of BepC and BepF differs from BepG-triggered invasome
formation in its requirement for cofilin-1, while the Rac1/
Scar1/WAVE/Arp2/3 and Cdc42/WASP/Arp2/3 signaling
pathways are required in both cases (Rhomberg et al.,
2009; Truttmann et al., 2011a, b, c).
Direct Bartonella spp.-mediated effects on
endothelial cell proliferation and migration
Bartonella bacilliformis
Early work on B. bacilliformis indicated that the bacterium
produces a mitogenic factor, that is, factor present in centri-
fugation-cleared bacterial sonicates, which is heat sensitive,
larger than 14 kDa in size and can be precipitated with 45%
ammonium sulfate (Garcia et al., 1990, 1992). Crude
extracts of B. bacilliformis were also analyzed in vivo. Polyvi-
nyl alcohol sponges were injected with the extract 3 days
after the sponges had been implanted subcutaneously into a
rat. Histological analysis of the sponges 7 days after implan-
tation revealed a 2.5-fold increase in the number of blood
vessels present in the sponges injected with 1 mg of
B. bacilliformis extract (Garcia et al., 1990). More recently,
it was reported that the culture supernatants of B. bacillifor-
mis contain a potent mitogen, which is heat sensitive and is
inactivated with trypsin, therefore indicating its proteina-
ceous nature. The authors provided evidence that this mito-
gen and most probably the mitogen identified by Garcia
et al. (1990) is the GroEL chaperon (Minnick et al., 2003a).
More studies are needed to define the GroEL function in
detail and the angiogenic properties of B. bacilliformis in
general because it has also been reported that B. bacilliformis
counterintuitively reduces EC migration in vitro as judged
by wound healing assays and single cell imaging (Verma
et al., 2001).
Apart from the possible bacterial proteinaceous mito-
gen(s), it has been proposed that the potent angiogenic
factor, angiopoietin-2 (De Palma & Naldini, 2011), has
an autocrine role in B. bacilliformis-induced EC prolifera-
tion (Cerimele et al., 2003). It was observed in vitro that
B. bacilliformis-infected ECs had higher amounts of
angiopoietin-2 mRNA. Accordingly, in situ hybridization
demonstrated that angiopoietin-2 is strongly expressed
in vivo by ECs of verruga peruana lesions. Moreover, the
major angiopoietin-2 receptor Tie2/Tek in addition to
Tie1 was expressed in verruga peruana ECs as shown by
immunohistochemistry (Cerimele et al., 2003). It remains
to be studied how B. bacilliformis induces the angiopoie-
tin-2 expression and whether this is significant in vivo in
the formation of verruga peruana lesions.
Bartonella quintana and B. henselae
Bartonella quintana and B. henselae appear to produce a
mitogenic factor, which is trypsin sensitive, therefore
indicating its proteinaceous nature (Conley et al., 1994;
Palmari et al., 1996). It appears that direct B. henselae–
EC interaction is not required to induce the proliferation
because culture supernatants of B. henselae induce the
proliferation of HUVECs (Maeno et al., 1999; McCord
et al., 2007), live B. henselae that have been physically
separated from ECs with a filter membrane induce the
proliferation (Maeno et al., 1999), and a nonpiliated
spontaneous mutant strain of B. henselae, presumably
BadA negative and therefore having reduced EC adhesion
capacity (Riess et al., 2004), possess the ability to stimu-
late the proliferation of co-cultivated HUVECs almost at
the same level as the parental piliated strain (Maeno
et al., 1999). The identity of B. henselae and B. quintana
mitogenic factor remains unknown and multiple factors
could be involved. GroEL has been detected in the cul-
ture supernatants of B. henselae, and it has been pro-
posed with analogy to B. bacilliformis that this factor
could be mitogenic (Minnick et al., 2003a; McCord et al.,
2007).
Apart from the possible bacterial proteinaceous mito-
gen(s), it has been proposed that interleukin-8 (IL-8),
which is a potent mitogen (Waugh & Wilson, 2008), has
an autocrine role in B. henselae-induced EC proliferation.
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Bartonella henselae infection of HUVECs and human
microvascular ECs (HMECs) induces the production of
IL-8 (Schmid et al., 2004; Kempf et al., 2005b; McCord
et al., 2006), and the B. henselae-induced proliferation of
HUVECs is inhibited by the addition of antibodies
against IL-8 (McCord et al., 2006). However, this mode
of action apparently requires direct bacterium cell contact
at least based on the lack of IL-8 secretion by HeLa cells
with the BadA-negative strain (Riess et al., 2004) and
therefore can only partially explain the mitogenic activity
of B. henselae. Recent report demonstrates that B. hense-
lae infection of human skin microvascular endothelial
cells (HskMECs) induces VEGF secretion under condi-
tions where VEGF secretion by HUVECs was not detected
(Berrich et al., 2011). Hypoxia-inducible factor-1 (HIF-1)
is one of the key transcription factors regulating angio-
genesis as an example via the VEGF expression (Lu &
Kang, 2010). Activation of HIF-1 has been detected in
B. henselae-infected HeLa cells and HUVECs in vitro
(Riess et al., 2004; Kempf et al., 2005b). HIF-1 is essential
for B. henselae-induced secretion of VEGF (Kempf et al.,
2005b), which is extremely potent in HeLa cells (Kempf
et al., 2001, 2005b) and HskMECs (Berrich et al., 2011)
but has also detected in HUVECs (Kempf et al., 2005b)
despite recent contradictory findings (Berrich et al.,
2011). Because the infection of HeLa cells with B. hense-
lae resulted in an increased oxygen consumption and sub-
sequent cellular hypoxia presumably because of
intracellular bacterial replication (Kempf et al., 2005b),
the B. henselae-mediated HIF-1 activation appears to be
oxygen dependent (Jaakkola et al., 2001). The intracellu-
lar replication-mediated hypoxia is supported by the
observation that the growth of B. henselae under in vitro
liquid growth conditions consumes oxygen and the
growth can be significantly increased by aeration of the
cultures (Chenoweth et al., 2004). The physiological
importance of HIF-1 activation and VEGF secretion is
supported by histology studies with intense staining pat-
terns for VEGF and HIF-1 in BA/BP tissue lesions
(Kempf et al., 2001, 2005b).
VirB/VirD4-T4SS and direct mitogenic activities of
Bartonella spp.
It has been reported that the secretion of IL-8 upon
B. henselae infection of HUVECs is dependent on VirB/
VirD4-T4SS (Schmid et al., 2004). It was observed that
for all infection doses tested (multiplicity of infection
(MOI) = 30, 100, 300), the VirB4-deficient strain was
attenuated in its capacity to induce the secretion of IL-8
as compared to the parental strain. The expression of
IL-8 is primarily mediated by NF-jB (Waugh & Wilson,
2008), and accordingly, the authors demonstrate that
NF-jB is activated upon B. henselae infection primarily in
a VirB/VirD4-T4SS-dependent manner (Schmid et al.,
2004). At the moment, it remains unknown which Beps
(Fig. 5) are involved. VirB/VirD4-T4SS has also been
implicated to negatively influence the mitogenic capacity
of B. henselae, which under the experimental setup could
have been mediated by bacterial mitogen(s) and/or possi-
ble autocrine stimuli (Schmid et al., 2004). It was
observed that for all infection doses tested (MOI = 10, 30
or 100), the VirB4-deficient strain strongly stimulated
HUVEC proliferation resulting on day 5 to an eightfold
increase in cell numbers, which even seemed to surpass
the effect caused by VEGF. In contrast, infection with the
wild-type B. henselae resulted only in a twofold increase
in cell numbers at the lowest dose tested (MOI = 10) and
the higher doses even appeared cytostatic (Schmid et al.,
2004). These data indicate that the potent mitogenic
activity of B. henselae is VirB/VirD4 independent and that
the VirB/VirD4-mediated cytostatic effects interfere with
the activity of the VirB/VirD4-independent mitogen(s) in
an infection dose-dependent manner. In the case of the
autocrine VEGF stimulus (see B. quintana and B. hense-
lae) or paracrine VEGF stimulus (see A paracrine loop of
Bartonella spp.-mediated endothelial cell proliferation), it
has recently been reported that B. henselae infection nega-
tively influences the VEGF signaling in HUVECs (Sche-
idegger et al., 2011). B. henselae infection abrogated
VEGF-induced proliferation of HUVECs and wound clo-
sure of HUVEC monolayers as well as the capillary-like
sprouting of EC spheroids. On the molecular level,
B. henselae infection inhibited VEGF-stimulated phos-
phorylation of VEGF receptor 2 (VEGFR2) at tyrosine
1175 but it did not alter the VEGFR2 expression or cell
surface localization. Inhibition of VEGFR2 signaling by
B. henselae infection was strictly dependent on a func-
tional VirB/VirD4-T4SS (Scheidegger et al., 2011). In
conclusion, VirB/VirD4-T4SS appears as an important
regulator of direct mitogenic activities of B. henselae. On
the one hand, it seems to be required to induce the secre-
tion of one potent autocrine mitogen, IL-8, from the
infected ECs. On the other hand, VirB/VirD4-T4SS coun-
terintuitively inhibits other direct mitogenic activities of
B. henselae, which may include the intrinsic bacterial
mitogen(s) or autocrine cellular mitogen(s) such as VEGF.
Inhibition of endothelial cell apoptosis
Inhibition of host cell apoptosis appears essential for
intracellular pathogens to establish chronic infections.
Pathogen-triggered anti-apoptosis of infected host cells is
expected to facilitate a slow microbial replication process
and enables persistence in the infected host. For example,
the obligate intracellular pathogens Chlamydia pneumo-
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niae and Chlamydia trachomatis degrade pro-apoptotic
BH3-only host cell proteins such as Bim, Puma, and Bad
(Fischer et al., 2004). Chlamydia pneumoniae has also
been reported to protect invaded host cells from apopto-
sis by activating a nuclear factor kappa B (NF-jB)-depen-
dent survival pathway in a similar fashion to Rickettsia
rickettsii (Clifton et al., 1998; Paland et al., 2006). In an
early study, it was reported that B. henselae and B. quin-
tana inhibit actinomycin D-induced apoptosis of human
dermal microvascular ECs and HUVECs (Kirby & Nekor-
chuk, 2002). More recently, it was shown that the capac-
ity of B. henselae to inhibit apoptosis of HUVECs,
induced either artificially by the transcriptional blocker
actinomycin D or more physiologically by cytotoxic T
lymphocytes, is dependent on the VirB/VirD4-T4SS and
its BepA effector (Schmid et al., 2004, 2006). BepA of
B. henselae has also been reported to promote capillary-
like sprouting of EC spheroids in 3D collagen matrix
(Scheidegger et al., 2009), most likely via its potent
capacity to promote cell survival. Translocation of BepA
into ECs coincides with an increase in cellular cAMP con-
centration (Schmid et al., 2006). Pharmacological eleva-
tion of cAMP by combined action of the adenylate
cyclase activatory drug forskolin and the phosphodiester-
ase inhibitory drug 3-isobutyl-1-methylxanthine or by
addition of the nonhydrolyzable and membrane-perme-
able cAMP analog dibuturyl-cAMP similarly protected
ECs from apoptosis (Schmid et al., 2006). This direct
phenocopy effect indicates that the BepA-induced cAMP
elevation is indeed the molecular basis of BepA-mediated
anti-apoptosis. The molecular mechanism how BepA
induces the cAMP elevation and the nature of the anti-
apoptotic signaling events downstream of cAMP elevation
are currently unknown. The observation that BepA medi-
ates the protection of B. henselae-infected ECs against
apoptosis triggered by cytotoxic T lymphocytes (Schmid
et al., 2006) suggests a physiologically relevant context in
which the anti-apoptotic activity of BepA contributes to
the vasoproliferative tumor formation in the chronically
infected vascular endothelium.
A paracrine loop of Bartonella spp.-mediated
endothelial cell proliferation
Monocyte/macrophages are capable of producing potent
angiogenic factors (Qian & Pollard, 2010). Bacterial acti-
vation of the typical BA/BP-lesion monocyte/macrophage
infiltrate (Kostianovsky & Greco, 1994) could therefore
result in the release of angiogenic substances and
thereby contribute to the process of vascular deforma-
tion. VEGF, one of the most potent mitogens of ECs
and inducers of angiogenesis (Eilken & Adams, 2010), is
released also from B. henselae-infected cells other than
HUVECs such as HeLa and Ea.hy926 cells (Kempf et al.,
2001; Riess et al., 2004; Kempf et al., 2005b). Accord-
ingly, conditioned medium of the B. henselae-Ea.hy926
co-culture induced the proliferation of HUVECs, which
was partially inhibited by the addition of anti-VEGF
antibodies (Kempf et al., 2001). These primary findings
were later substantiated by an observation that phorbol
12-myristate 13-acetate (PMA)-differentiated or undiffer-
entiated THP-1 human macrophages secrete VEGF upon
B. henselae infection and that medium of the B. hense-
lae-THP-1 co-culture induces the proliferation of
HMECs (Resto-Ruiz et al., 2002). Moreover, J774A.1
murine macrophages have been reported to release
VEGF upon B. henselae infection (Kyme et al., 2005) and
THP-1 human macrophages upon B. quintana infection
(Schulte et al., 2006). These data are in favor of a paracrine
loop of Bartonella spp.-mediated EC proliferation, with
VEGF representing the major angioproliferative substance
released by macrophages in response to B. henselae infec-
tion. Of note, B. henselae strain Marseille has been reported
to enter J774A.1 mouse macrophages in the absence of
opsonins and is capable of delaying its lysosomal targeting
and destruction at least when compared in parallel with
L. innocua (Kyme et al., 2005). In an independent study, it
was shown that B. henselae strain Houston-1 enters and
stays viable at least for up to 8 h in J774 mouse macro-
phages (Musso et al., 2001). Therefore, it appears that
B. henselae persists inside the macrophages. Although these
bacteria do not apparently gain anything per se, as the
BCVs eventually fuse with the lysosomes (Kyme et al.,
2005), it can be speculated that the invaded bacteria pro-
gram the paracrine angiogenic loop of macrophages to
benefit the common good of the rest of the bacterial popu-
lation that colonizes the vascular endothelium. Interest-
ingly, it has been reported that B. henselae inhibits
apoptosis of human macrophage-like MonoMac 6 cells in
an NF-jB-dependent manner (Kempf et al., 2005a). This
indicates that the bacterium might be able to prolong the
lifespan of the angiogenically programmed macrophages.
The mechanism how Bartonella spp. could activate VEGF
production in macrophages remains elusive but most likely
is analogous to the apparent oxygen-dependent activation
of HIF-1 in infected HeLa cells (Kempf et al., 2005b).
Leukocyte homing to the site of infection
Monocyte chemoattractant protein-1 (MCP-1) is a potent
chemoattractant for monocytes and macrophages to home
to areas of bacterial inflammation (Melgarejo et al., 2009).
As an example, E. coli LPS is an extremely potent inducer
of MCP-1 expression and secretion in HMECs, and this
proceeds in an NF-jB-dependent manner (McCord et al.,
2005). LPS of B. henselae does not activate MCP-1
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expression in the same cells (McCord et al., 2005), which is
in accordance with the observation that the purified LPS
from B. henselae is 1000–10 000-fold less active than the
purified LPS from S. enterica sv Friedenau in activating
TLR4 signaling (Za¨hringer et al., 2004). However, intact
B. henselae, in particular its OMPs, activate MCP-1 expres-
sion and secretion in an NF-jB-dependent manner (Kempf
et al., 2005a, b; McCord et al., 2005). The physiological
significance of these findings in the B. henselae-triggered
vascular deformations remains open because MCP-1
expression and secretion is expected to take place by any
given bacterial infection (Melgarejo et al., 2009). However,
the unusual location of the chronic Bartonella spp.
infections in vascular ECs could position the migrating
monocytes and macrophages to favor the paracrine
angiogenic loop mediated by these phagocytic cells.
PMNs are actively recruited to the site of microbial
infection (Borregaard, 2010), which in the first place
involves sequential establishment of receptor–ligand inter-
actions between the activated ECs and circulating PMNs.
ECs react to inflammatory cytokine stimulus and upregu-
late the expression of receptors such as E-selectin that is
recognized by the constitutively expressed adhesins on
PMNs resulting in PMN rolling on the surface of ECs.
Induction of E-selectin expression has been observed in
B. henselae-infected HUVECs in an NF-jB-dependent
manner (Fuhrmann et al., 2001). The key molecules medi-
ating subsequent firm adhesion of neutrophils to the acti-
vated endothelium are the b2 integrins, present on PMNs,
and their ligands, members of the immunoglobulin super-
family, intercellular adhesion molecule-1 (ICAM-1) and
ICAM-2, present on the ECs. Induction of ICAM-1 expres-
sion has been observed in B. henselae-infected HUVECs in
an NF-jB-dependent manner (Fuhrmann et al., 2001;
Maeno et al., 2002). Moreover, this upregulation appears
to be mediated primarily by VirB/VirD4-T4SS (Schmid
et al., 2004) by a yet unknown Bep(s), although contribu-
tion of VirB/VirD4-T4SS independent factor(s), possibly
OMPs as proposed by Fuhrmann et al. (2001), is clear
(Schmid et al., 2004). In accordance with the detected
upregulation of ICAM-1 and E-selectin of B. henselae-
infected ECs, it has been demonstrated that PMN rolling
and adhesion ( 30 s of stable contact) to ECs is signifi-
cantly increased upon B. henselae infection (Fuhrmann
et al., 2001). At first glance, PMN homing to the inflamed
vasculature appears only detrimental for B. henselae. How-
ever, PMNs are a potent source of VEGF (Gaudry et al.,
1997), and VEGF secretion by PMNs has been detected
upon Streptococcus pneumoniae infection (van Der Flier
et al., 2000) as well as it seems to be present in high con-
centrations in cerebrospinal fluid in bacterial meningitis
(van Der Flier et al., 2000; van der Flier et al., 2001). Per-
haps B. henselae triggers VEGF secretion also by PMNs and
engage an additional cell type to its paracrine angiogenic
loop.
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